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Abstract 
Chronic kidney disease is a progressive and irreversible kidney damage associated with 
decreased glomerular filtration rate. This purpose of the study was to identify the 
relationship between adherence to diet, fluid, medication, and blood pressure in pediatric 
patients with CKD undergoing hemodialysis in governmental hospitals in Gaza Strip. The 
study utilized a descriptive, cross-sectional design. The population of the study consisted 
of 49 children, and the sample of the study consisted of 43 children with CKD and 
undergoing hemodialysis (census) with response rate 87.7%. The researcher developed a 
questionnaire for data collection. The questionnaire consisted of sociodemographic 
characteristics, adherence to diet, adherence to fluid restriction, measurement of Blood 
Pressure, role of the nurse in monitoring adherence, and Morisky Medication Adherence 
Scale (MMAS). The questionnaire distributed to a panel of experts for content validity, and 
a pilot study carried out on 20 children to check reliability of the questionnaire, and 
Cronbache alpha for the role of the nurses in monitoring the adherence was 0.79 and for 
MMAS was 0.92. The researcher used SPSS version 22 for data analysis. Statistical 
analysis included frequencies, percentage, means, standard deviation, independent (t) test, 
One way ANOVA, and Pearson correlation test. The results showed that 69.8% of study 
participants were male children and 30.2% were female children, with mean age 
11.78±4.52 years, 44.2% had primary school education and 30.2% were preschoolers. In 
addition, 88.4% of study participants had hypertension, and on dialysis for 6 months to 8 
years with mean 3.73±2.26 year. Furthermore, The results indicated poor adherence to diet 
as pre-dialysis serum K
+
 ranged from 4.27 to 7.27 mg/dl (m= 5.49±0.77 mg/dl), pre-
dialysis serum PO4 ranged from 2.67 to 11.83 mg/dl (m= 6.52±1.98 mg/dl), pre-dialysis 
serum BUN ranged from 55.33 to 292.0 mg/dl (m= 161.04±52.42 mg/dl). Interdialytic 
weight gain ranged from 0.10 g to 3.83 kg (m= 1.73±0.86 kg). The results also indicated 
low adherence to antihypertensive medication among CKD patients with mean score 4.5 
on Morisky scale with 84.2% of children lad low adherence to medication.The nurses 
showed high level (95.65%) of monitoring the adherence of their patients concerning diet, 
fluid intake, and medication. In general, the results showed that 7% of study participants 
were fully adhered to diet, 88.4% were fully adhered to fluids intake, and 36.8% were fully 
adhered to anti-hypertensive medication. Mean systolic BP at pre-dialysis phase was 
129.66±19.50 mmHg and mean diastolic BP was 78.58±13.52 mmHg. There was 
statistically significant correlation between diastolic BP and fluid intake (P= 0.03), diet and 
medication (P= 0.04), and between BP and number of hours per session of dialysis. There 
were statistically no significant differences in SBP and DBP related to gender, age, place 
of residency, family income, parents’ level of education, and years on dialysis, while 
secondary school children had significant higher DBP, and children from Al Rantesy 
hospital had significantly lower SBP and DBP. In addition, 12 years old and more and 
secondary schoolchildrenshowed higher adherence to fluid intake. Moreover, children on 
dialysis for less than five years had higher level of BUN and lower adherence to fluid 
intake. The study concluded that interventions should focus on both patient factors and 
system problems that compromise the patient's ability to adhere to treatment program. 
However, nurses’ role is important in identifying barriers to adherence, and offer strategies 
to help patients improve adherence to treatment program. 
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1 Chapter One 
Introduction 
1.1 Background 
The kidney is important for body to maintain normal blood pressure (BP) and kidney 
failure can lead to HTN (Cui et al., 2011). HTN is highly prevalent in patients with chronic 
kidney disease (CKD) and the prevalence increased in patients with ESRD. In addition, 
74% of pediatric patients undergoing hemodialysis (HD) in America were hypertensive. 
However, to control HTN among patient undergoing HD; the patient must adhere to very 
restricted diet and fluid intake, adherence to prescribed medications and committed to 4 
hours dialysis sessions 3 times a week (Ikonomou et al., 2015).  
End stage renal disease (ESRD) is that stage when kidney impairment is irreversible, 
cannot be controlled by conservative management alone, and requires renal replacement 
therapy (dialysis or kidney transplantation) to maintain life (National Kidney Foundation, 
2010). According to the latest statistics, the prevalence rate of ESRD in the West Bank 
(WB) was 240.3 per million populations and 320 per million populations in Gaza Strip 
(GS) (Khader et al., 2013). In the GS, the risk factors associated with ESRD were 
hypertension (HTN), glomerulonephritis, obesity, and low monthly income (Abu-Odah, 
2017). 
Khalil and Darawad (2014) found that adherence to diet and fluid among Jordanian HD 
patens not exceeds 30 %. Moreover, Alsmadi, et al., (2008) found that above 70 % of 
dialysis patients with uncontrolled BP withheld their antihypertensive medications. Non-
adherence to therapeutic recommendation affects quality of life and the mortality rate for 
patients with ESRD remain high because of high rate of non-adherence to dialysis session 
which lead to death occurs from build-up of fluids and waste products in the body 
(Fischbach and Zaloszyc, 2015). Adherence influenced by multiple factors related to the 
patient, the treatment or condition, the health care providers and the clinical care setting 
(Viswanathan et al., 2012). Hypervolemia considered a major pathogenic factor and better 
control of fluid status would more effetely prevent the damaging effects of fluid overload 
and hypertension. Fluid removal by ultrafiltration (UF) during hemodialysis is commonly 
the first-line therapy used to manage HTN in dialysis patients, however, aggressive fluid 
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removal may lead to interdialytic hypotension, with reduction of blood flow to vital organs 
(Fischbach, et al., 2015).   
Fluid overload between dialysis sessions measured by interdialytic weight gain (IDWG). 
The relationship between IDWG and BP may vary between children of different age and 
may be affected by growth and associated variations, and necessary fluid intake to meet 
nutritional needs (Zaloszyc et al., 2013). Therefore, an individualized approach to 
management of fluid retention and HTN in pediatric patients is necessary.  
Although several studies investigated how IDWG relates to blood pressure control in 
dialyzed children, the effect of residual urine output on IDWG and pre-dialysis BP in these 
population has not been studied (Paglialonga et al., 2015). Importantly, children with 
chronic HD, the IDWG reflects not only water and sodium intake, but also nutritional 
intake that is essential for growth (Huang et al., 2014). However, dietary intake should not 
be reduced in an attempt to achieve a safe ultrafiltration rate. 
1.2 Problemstatement 
Patients and children undergoing HDmust keep their potassium levels between 3.5 and 5.5 
mg/dl, excessive dietary potassium intake may lead to hyperkalemia and fatal cardiac 
rhythm abnormalities, they must also keep their phosphate levels between 3.4 and 4.5 
mg/dl, elevated serum phosphate levels or phosphate retention can lead to renal 
osteodystrophy and may contribute to cardiovascular disease (Hezel et al., 2016).  A study 
of Naalweh et al., (2017) showed that dietary adherence was observed in 24% while that of 
fluid restriction adherence was observed in 31% of studied patients in Palestine, but there 
is no previous study of adherence among children with ESRD in Palestine. 
Moreover, children with CKD are limited to approximately 700 - 1000 ml of fluid per day 
and must keep their fluid weight gains between 0.5 and 1 kg per day, Excess fluid can 
result in fluid build-up around the lungs, causing shortness of breath and high blood 
pressure. Prolonged fluid overload is associated with HTN, pulmonary edema, congestive 
heart failure, and shortened patient survival. To this end, dietary and fluid adherence is of 
crucial importance to the quality of life and survival of HDpediatric patients (Hezel et al., 
2016). Despite a high prevalence of HTN among pediatric patients with ESRD, many 
studies reported that BP control still inadequate.  
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Previous studies have showed that the adherence rates to HTN treatment have been 
reported to range between 30 to 60% among patients with ESRD (Denhaerynck et al., 
2007). In addition, the study of Alsmadi et al., (2008) in Jordan found that 67.2% of 
patients treated with regular HD had uncontrolled BP. However,non-adherence is a 
possible reason for uncontrolled HTN in patients with ESRD that leads to unhealthy self-
care behaviors such as excessive sodium and fluid intake. 
More importantly, the adherence of children undergoing HD is considered a critical point 
in the child’s life, they need supervision from the family and from the nurse or health 
specialist, because they are at risk for cardiovascular disease, left ventricular hypertrophy 
due to fluid overload, congestive heart failure, and cerebrovascular diseases. Furthermore, 
non-adherence to the above mentioned affects the child’s quality of life (Khalil and 
Darawad, 2014). 
The problem raises here is that; there is no specific and clear role belonging to the nurses 
working in HD units which adopts following up the adherence of children and the patients 
to diet, fluid and medications, so, this study came to examine the correlation between fluid 
and diet adherence and BP control in pediatric patients with ESRD undergoing HD to show 
whether adequate control of volume status, diet and medication and adequate estimation of 
dry weight would effectively normalize blood pressure. The issue of adherence among 
pediatric patients is ignored in HD unit, this issue needs more attention and more research 
as well. 
1.3 Justification of the study 
This study may have great benefits and significance on multi levels, this study would have 
its benefits for the children since the adherence to diet and fluids lead to decrease BP and 
decrease the risk for future complications, increase patients’ life expectancy, enhance the 
quality of life for both “child and his/her family” as well. The results of this study also may 
save huge efforts spent by the nurses in the hemodialysis unity in providing specific care to 
those children and may decrease the number of sessions especially in the evening and night 
time; the issue that is considered more critical and sensitive for the nurses and nursing 
mangers in the Gaza Strip. Furthermore, the results of this study may save the huge burden 
spent by the ministry of health for those children in terms of financial costs and managerial 
issues. Lastly, based on the researcher’s knowledge, there are no studies conducted in 
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Palestine especially in the Gaza Strip regarding the issue of blood pressure control among 
pediatric patients undergoing hemodialysis. 
1.4 Aim of the study 
The aim of this study is to examine the correlation between adherence to fluid, diet and 
medication, and blood pressure among children undergoing hemodialysis in the Gaza Strip.   
1.5 Specific objectives 
1. To determine the level of adherence to fluid, diet and medication among pediatric 
patients undergoing hemodialysis in the Gaza Strip. 
2. To examine the correlation between blood pressure and adherence to fluid, diet and 
medication among pediatric patients undergoing hemodialysis. 
3. To explore if there are significant differences in adherence based on (children age, 
gender, number of dialysis years, residence, and socioeconomic status of the family). 
4. To identify the role of the nurses working in hemodialysis units in monitoring the 
adherence of pediatric patients to fluid, diet and medication. 
5. To suggest recommendations for policy makers which may help in developing specific 
system to monitor the adherence of pediatric patients in the Gaza Strip 
1.6 Research questions 
1. What is the level of adherence to fluid, diet and medication among pediatric patients 
undergoing hemodialysis in the Gaza Strip? 
2. What is the level of adherence to medication scale among pediatric patients with CKD 
undergoing hemodialysis in Gaza Strip? 
3. Is there a significant relationship between blood pressure and adherence to diet, fluid 
and medication among pediatric patients with CKD undergoing hemodialysis in Gaza 
Strip?  
4. Are there significant differences in adherence to diet, fluid, and medication related to 
(children age, gender, and number of dialysis years, residence, and socioeconomic 
status of the family)? 
5. What is the role of nurses who are working in hemodialysis units in encouraging the 
adherence to diet, fluid and medication among pediatric patients with CKD in Gaza 
Strip? 
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1.7 Context of the study 
1.7.1 Sociodemographic context 
Palestine lies within an area of 27,000 square kilometers (Km
2
), expanding from Ras Al-
Nakoura in the north to Rafah in the south. Due to the Israeli occupation, the Palestinian 
territory is divided into three areas separated geographically; the West Bank (WB) 5.655 
Km
2
, GS 365 Km
2
 and East Jerusalem, with estimated population about 4,95 million, of 
them 3,008 in WB and over 2 million in GS with male to female ration 103.4. The 
population density (capita/km
2
) is 778 in Palestine (506 in WB and 4,986 in GS).The 
Palestinian population is characterized by high percentage of young age as the percentage 
of people younger than 5 years was 15% (13.8% in WB and 17% in GGS, and those aged 
between 0 – 14 years accounted for 39.4% (37.2% in WB and 43% in GS) (Palestinian 
Central Bureau of Statistics - PCBS, 2018). 
1.7.2 Economic context 
The Palestinian economy is under high pressure to create decent and productive jobs, 
reduce poverty and provide economic security on an equal basis for all social groups in a 
rapidly growing and urbanizing population. Economic status in the Palestinian territories is 
very low. Gross Domestic Product is estimated about 9.3%, and the workforce 
participation 43.6, unemployment is very high and reached a rate of 26.9% for males 
(15.5% in WB and 34.4% in GS) and for females unemployment rate is 44.7% (29.8% in 
WB and 65.2% in GS) (PCBS, 2017). Due to blockade of the strip, a significant increase in 
poverty rates occurred in GS from 38.8% in 2011 to 53% by the end of 2017 (United 
Nations Office for the Coordination of Humanitarian Affairs - OCHA, 2018). 
1.7.3 Health care system 
ThePalestinianhealthsystemcompose ofdifferent sectors. 
ThemajorgroupsofhealthprovidersaretheMOH,Non-governmental organizations 
(NGOs),UnitedNationsReliefandWorksAgencyforPalestinianRefugees in the Near East 
(UNRWA),Military Health Services, andtheprivatesector.The total number of hospitals in 
Palestine is 81 hospitals, 51 of them in WB including east Jerusalem. The MOH is 
responsible for 27 hospitals (14 hospitals in WB and 13 hospitals in GS). The number of 
beds allocated to admit children accounted for 19.3% of the total number of beds in MOH 
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hospitals (260 beds in WB and 381 beds in GS).  In GS, there are four governmental 
hospitals that offer HD for adults (Al Shifa Medical Complex, Nasser Medical Complex, 
Shohada Al Aqsa Hospital, and Al Najar Hospital), and Al Rantesy Specialized Pediatric 
Hospital is the only one that offer HD service to pediatric patients with CKD (MOH, 
2017). 
Hemodialysis is available in five governmental hospitals in GS, of them four hospitals for 
adult patients (Al Shifa hospital, Shohada Al Aqsa, Nasser hospital, and Al Najar hospital) 
with a total of about 110 HD machines. In addition, Al Rantesy Specialized Pediatric 
Hospital is the only hospital that offer HD services to pediatric patients with CKD 
equipped with 15 HD machines. The total number of patients registered with ESRF 
undergoing HD is 710 patients, of them 50 patients are children (MOH, 2018).  
1.7.4 The status of children in Palestine 
The Palestinian community is characterized as young age population. Young age 
accounted for a considerable large proportion of the population as the percentage of 
children aged 0 - 14 years is 38.9% (36.6% in WB and 42.6% in GS), and those aged 
between 15 – 29 years accounted for 29.7% (29.9% in WB and 29.5% in GS) (PCBS, 
2018). The number of children under the age of 18 is 2,115,370 children in Palestine 
according to the results of Population, Housing and Establishments Census 2017. The 
percentage of children in Palestine is 45.3% of the population (43.4% in WB and 48.0% in 
GS) (PCBS, 2018).  
Concerning children's health-related statistics, 0.9% of the children have at least one form 
of disability (0.7% in WB and 1.2% in GS). The main causes of disability among children 
included congenital or genetic causes ranked first by 45.5% (43.5% males and 48.3% 
females), followed by causes related to pregnancy and childbirth 23.3% (22.8% males and 
24.1% females), then 21.1% for pathological causes (22.2% males and 19.6% females) 
(PCBS, 2018).Concerning education, enrollment of children in basic education (6 – 15 
years) in GS reached 94.3% for male children and 95.9% for female children. There are 
443,425 children enrolled in basic education in GS (223,928 males and 219,497 females), 
and classroom density was 36.9 (37.1 in governmental schools and 39.0 in UNRWA 
schools) (PCBS, 2017). 
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1.8 Operational definitions 
Adherence  
Adherence defined as the extent to which a patient's behavior - taking medication, 
following a diet, and/or executing lifestyle changes, corresponds with agreed 
recommendations from a health care provider (WHO, 2019). 
The researcher defined the adherence to diet operationallyby serum level of potassium < 
5.5 mg/dl, serum phosphorus < 5.5 mg/dl and serum BUN < 100 mg/dl. 
The researcher defined adherence to fluid restriction operationally by the amount of 
child’s weight gain between dialysis sessions.  
The researcher defined adherence to medication operationally based on the scores 
obtained on Morisky Medication Adherence Scale. The child will be considered having 
high adherence if he/she has zero score on Morisky scale, medium adherence (1 – 2) score, 
and low adherence (3 – 8) score. 
Interdialytic weight gain  
Interdialytic weight gain (IDWG) is an easily measurable parameter in the dialysis unit, 
routinely assessed at the beginning of the dialysis session, and used along with clinical 
symptoms, signs, and predialytic BP readings to make decisions regarding the amount of 
fluid removal during a dialysis session. IDWG is also used as a basis for fluid and salt 
intake recommendations(Sarkar et al., 2006). 
 The researcher calculated IDWG by subtracting the child's weight upon the arrival to the 
dialysis unit from the weight at the end of previous session. 
Blood pressure control 
The researcher defined the blood pressure control operationally if it is less than 140/90 
mmHg before dialysis and less than 130/80 mmHg after dialysis.   
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2 Chapter Two 
Conceptual framework and literature review 
2.1 Conceptual framework 
 
 
 
 
 
 
 
Figure (‎2.1): Diagram of conceptual framework 
Figure (2.1) illustrates the conceptual framework for the study; the framework consists of 
three domains, the first domain which is the child demographic data such as age, gender, 
years of dialysis and socioeconomic status of the family, this domain is considered 
independent for the child adherence to diet, fluid and medication. The second domain is the 
child adherence to diet, fluid and medication which is considered as independent for the 
last dependent domain which is blood pressure control. 
2.2 Literature review 
2.2.1 Background 
Chronic kidney disease is a major health problem worldwide. CKD is a progressive and 
irreversible kidney damage associated with decreased glomerular filtration rate (GFR). The 
filtration and renal regulation failure generates the accumulation of toxic substances in the 
body, triggering water, electrolyte, acid-base, endocrine and metabolic disorders (Kalantar 
et al., 2016). Due to the complex and demanding medical regimen, these patients require 
extensive life-style changes, including adherence to prescribed medications, caring for 
Child 
Demographic 
Data 
A Adherence to 
 
Control of 
 Age, Gender  
 Years on dialysis 
 Socioeconomic 
status 
 Diet  
 Fluid  
 Medication  
 
Blood pressure  
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vascular access, dietary recommendations that include selecting food low in sodium, 
potassium and phosphorus, maintaining adequate protein intake, and limiting daily fluid 
intake (Smith et al., 2010). On the other hand, noncompliance to these dietary 
recommendations may lead to accumulation of metabolic by products and excess fluid in 
the circulatory system, leading to increased morbidity and mortality for renal failure 
patients (Ahrari et al., 2014). 
2.2.2 Etiology and risk factors of chronic kidney disease in children 
Chronic kidney disease is a clinical syndrome characterized by a gradual loss of kidney 
function over time. According to the Kidney Disease: Improving Global Outcomes 
(KDIGO) guidelines, CKD is identified by the presence of kidney damage, either 
functional or structural, or by a decline in GFR below 60-mL/min/1.73 m
2
 of body surface 
area for more than 3 months (KDIGO 2013).  
In fact, the primary causes of CKD in pediatric patients vary from those causes that are 
responsible for the adult onset of the disease. Common predisposing factors for CKD in 
pediatric patients include steroid-resistant nephrotic syndrome accounting for (49.1%) of 
cases, chronic glomerulonephritis (10.4% lupus nephritis, 8.1% Alport syndrome), and 
renal ciliopathies (5.3%) of cases (Vivante and Hildebrandt, 2016; Harambat et al., 2012; 
Smith et al., 2010). Moreover, less common causes of CKD include thrombotic 
microangiopathies especially atypical hemolytic uremic syndrome, nephrolithiasis, Wilms 
tumor (a type of cancer that starts in the kidneys), infectious and interstitial diseases 
(Vivante and Hildebrandt, 2016).  
Furthermore, structural causes such as renal hypoplasia or posterior urethral valves are 
clearly predominate in children, and the incidence of glomerulonephritis increases in those 
>12 years old. In addition, reductions in nephron numbers observed in low-birth weight 
and small for gestational age newborns are considered as predisposing factors to CKD in 
pediatrics (Cain et al., 2010; Schreuder, 2012). In a recent report about causes of CKD, the 
most common causes were congenital causes, including congenital anomalies of the kidney 
and urinary tract (CAKUT) accounted for 48% of cases, glomerulonephritis accounted for 
14% of cases, and hereditary nephropathies accounted for 10% of the cases. Furthermore, 
CAKUT was more common among younger patients, while glomerulonephritis was more 
common among children older than 12 years of age (Harambat et al., 2012). 
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In the United States, CAKUT and hereditary nephropathies were the most common causes 
of CKD in the young patients, while CAKUT accounting for 34 to 43% of pediatric CKD 
cases in Europe, Japan, Australia, and New Zealand (Lewis et al., 2010).  
In Turkey and other countries in the Middle East, CAKUT were the leading cause of CKD 
accounting for 47 - 62% with predominance of uropathies over hypodysplasia. In addition, 
hereditary nephropathies accounted for 17 to 30%,neuropathic bladder accounted for 15% 
of cases in Turkey, while it accounted for about 4% in Italy and Belgium (Harambat et al., 
2012).  
In 2008, the proportion of CKD caused by glomerulonephritis was lower in Europe 
according to the ESPN/ERA-EDTA registry (15%) compared with a Japanese study (22%) 
and the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA; 29%). 
The ANZDATA Registry showed a decline in glomerulonephritis as a cause of ESRD over 
time. However, this may be due to the age distribution of patients, with fewer young 
patients being treated for CKD at that time. There was also a decline in the proportion of 
ESRD caused by reflux nephropathy, while obstructive uropathy and hypodysplasia 
increased (Orr et al., 2009). This trend may be explained by a change in reporting the 
primary diagnosis, since the combined proportion of hypodysplasia and reflux nephropathy 
has remained stable over the past 30 years. 
A study carried out in Spain found that structural anomalies was the primary cause of 
pediatric CKD accounted for 59% of the cases,  glomerular diseases was very low 
accounted for 3% of cases, and male children were higher and represented 66% of cases 
(Trapote et al., 2010). In Sub-Saharan Africa, Cameron, the most common causes of CKD 
were chronic glomerulonephritis accounted for 56.2% of cases and urologic malformations 
mainly posterior urethral valves accounted for 43.8% of cases (Halle et al., 2017). 
Moreover, a study carried out in Egypt reported that the most common causes of CKD 
included obstructive uropathy (21.7%) of cases, primary glomerulonephritis (15.3%), 
reflux/urinary tract infection (14.6%), aplasia/hypoplasia (9.8%), familial/metabolic 
diseases (6.8%), and unknown causes (20.6%) of the cases (Safouh et al., 2015). 
2.2.3 Epidemiology of Chronic kidney disease in children 
There is limited information on the epidemiology of the early stages of CKD in the 
pediatric population as it is often asymptomatic and therefore under-diagnosed and under-
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reported. Although some pediatric CKD registries are beginning to emerge, only a few 
reports on the epidemiology of CKD stages 2 to 5 in children are available, and even less is 
known about low-income countries (Harambat et al., 2012).  
In Europe, it has been reported that the incidence of pediatric CKD around 11 - 12 per 
million of age-related population (pmarp) for stages 3 to 5, while the prevalence was 
around 55 - 60 pmarp (Harambat et al., 2012; ESPN/ERA-EDTA registry, 2016). In Spain, 
the incidence of pediatric CKD was 8.66 per million pediatric population (pmpp) and the 
prevalence was 71.06 pmpp (Trapote et al., 2010). In Brazil, the incidence of children with 
CKD on dialysis treatment was 6.6 pmarp, and the prevalence of pediatric CKD was 20 
pmarp (Konstantyner et al., 2015). 
In the United States of America (USA), the prevalence of CKD stages 1 - 4 estimated at 
15.5% - 18.3% (Centers for Disease Control and prevention – CDC, 2017). In Sub-Saharan 
Africa, CKD accounted for 15.5% and stage 5 was the most frequent (Halle et al., 2017). 
In Egypt, children with CKD stage 1 and 2 accounted for 4.4% of the cases, while those 
with stage 3, 4 and 5 accounted for 19.7%, 18.3% and 57.6%, respectively (Safouh et al., 
2015).  
Reports from governmental hospitals in GS indicated that there are 50 children with CKD 
and on regular hemodialysis during the year 2018 (Al Rantesy Pediatric Hospital, 2018). 
2.2.4 Hypertension in pediatric patients with chronic kidney disease 
Kidney function is vital to the maintenance of BP because the kidney is the primary 
regulator of blood volume, thus, decreased kidney function may be directly related to 
increased BP (Gallibois et al., 2017). 
Hypertension is highly prevalent in both adult and pediatric CKD patients on HD. Kramer 
et al., (2011) found that HTN is more prevalent in younger age HD because they are less 
adherent to diet and fluids than older age. However, the etiology of HTN in these patients 
is complex with extracellular volume playing a major role in addition to increased vascular 
constriction.  
Secondary forms of arterial HTN predominate in infancy and childhood. Renal HTN is the 
most common (approximately 85%) identifiable secondary HTN in children. It is one of 
the earliest and most prevalent complications of pediatric CKD. Over a half of all children 
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have HTN even in early CKD, increasing up to 50-75% in CKD stage five (Peco-Antic and 
Paripovic, 2014). 
Management of HTN in pediatric HD patients should include the establishment and 
maintenance of the appropriate dry weight through limitation of interdialytic sodium/fluid 
intake and adequate removal of these substances during HD. Pharmacologic therapy should 
include Angiotensin Converting Enzymes (ACE) inhibitors or Angiotensin Receptors 
Blockers as first-line agents, also these medications improve left ventricular hypertrophy 
and pulse wave velocity. Therefore, it is likely that increased dialysis time through either 
daily or nocturnal HD allows for better control of BP (Hinkle and Cheever, 2013). 
There is no confirmed evidence to base what BP target should be achieved, the current 
recommendations are to achieve systolic BP < 140 mmHg pre-HD or <130 mmHg post-
HD in adults and at least a BP <90
th
 percentile of the age, sex, and height appropriate level 
in the pediatric population (Peter et al., 2012). However, Kramer et al., (2011) reported that 
poor control of HTN presented in 69.4 % of HD, 68.6 % of peritoneal dialysis, and 66.9 % 
of transplant recipients.  
Blood pressure in HD pediatric patients have to be measured carefully and consistently, so 
that reliable BP data will be available to guide treatment. Ambulatory BP monitoring 
(ABPM) may also play important role in BP assessment in this population. In addition, 
twenty-four-hour ABPM is known to better predict cardiovascular morbidity than casual 
BP measurement and 24-h ABPM had better delineate cardiovascular morbidity in 
pediatric hemodialysis patients (Katsoufis et al., 2014). However, greater efforts should be 
made to control BP among pediatric ESRD patients, particularly within the first year of 
their starting RRT. Early control of HTN may be particularly important in reducing future 
cardiovascular risk. No specific antihypertensive group used to control BP in pediatric HD 
patients and individualized approach to HTN management is necessary (Peter et al., 2012).      
In the pediatric CKD patients, HTN often goes unrecognized or is inadequately controlled 
(Halbach and Flynn, 2015; Mitsnefes et al., 2010).  
Among children, HTN is a rare condition with prevalence of 3% to 9%, but in children 
with renal disorders, it can be present from the earliest stages of the disease and its 
prevalence increases as GFR progressively declines, and the prevalence of HTN rises up to 
50% of pediatric patients (Samuels et al., 2012; Mitsnefes, 2012). Moreover, Mitsnefes et 
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al., (2010) reported that HTN was present in 54% of patients and 48% of the children had 
high BP levels despite the use of antihypertensive medications, while Agarwal et al., 
(2014) reported that 76% of children on chronic dialysis had HTN.  
2.2.5 Association between blood pressure and fluid restriction and diet 
The main cause of HTN among HD patients is fluid overload. In this regard, Marsenic et 
al., (2016) found a positive relationship between IDWG and pre-dialysis BP in pediatric 
patients. Moreover, children undergoing chronic HD are at risk of CVDs and often develop 
left ventricular hypertrophy due to fluid overload. The role of IDWG in HTN is poorly 
defined; while some reported that over hydration as the main cause of HTN, others find 
that it is frequently not associated with HTN, in both adults and children (Zaloszyc, et al., 
2013; Van & Inrig, 2012). Removal of fluid during HD is the first-line treatment to 
manage HTN in dialysis patients. However, aggressive fluid removal may lead to 
interdialytic hypotension, with reduction of blood flow to vital organs (Daugirdas et al., 
2015; Fischbach, et al., 2015). 
The relationship between IDWG and BP may vary between children of different ages and 
size, and may be affected by growth and associated variations in total body water, dry 
weight (DW), and necessary fluid intake to meet nutritional needs, as well as nonadherence 
to medications and fluid restriction (Zaloszyc et al., 2013). Therefore, an individualized 
approach to management of fluid retention and HTN in pediatric patients is necessary. In 
this regard, Koc et al., (2011) found that increased IDWG lead to elevated BP, and 
Paglialonga et al., (2015) reported that increased fluid volume leads to IDWG, elevated 
BP, and eventually causes the risk for left ventricular hypertrophy increases.  
Calculation of IDWG is an important indicator for adherence to fluid restriction. It is worth 
to say that large fluctuations in IDWG result in extracellular volume expansion and 
elevated blood pressure, placing increased strain on the cardiovascular system (Lewicki et 
al., 2013). IDWG results from water accumulation in the body from metabolism and 
dietary and fluid intake. Thirst, prompted by the osmotic stimulus that results from excess 
dietary sodium intake and dialysate sodium, also plays a significant role in IDWG. To 
minimize IDWG, HD patients are advised to make lifestyle modifications including 
restriction of free fluid intake and minimize dietary sodium intake, but even though these 
lifestyle modifications are essential to the well-being and survival of HD patients, 
adherence is poor (Walsh and Lehane, 2011). 
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Dietary preferences and behaviors are highly individual and highly variable. It is obvious 
to say that diet-related decisions are influenced by multiple factors, including taste, 
financial constraints, individual preferences, social status, educational level, societal 
norms, health, relationships, trust in food sources, and convenience (Wyndels et al., 2011; 
Holmberg et al., 2010). 
For patients with CKD and on HD program, adherence to dietary regime is challenging due 
to the burden of constant choices about food and drink, the adaptation to complex eating 
patterns, existing cultural practices, and the competing demands of this chronic disease and 
related illnesses (Walker et al., 2012). 
A descriptive, analytical study aimed to identify characteristics of HD patients most likely 
to experience difficulty adhering to sodium restrictions associated with their dietary 
regimen. The results showed that younger participants were more likely to report problems 
managing their HD diet and low self-efficacy for restricting sodium intake. Younger 
participants had a higher median sodium intake and higher average adjusted IDWG. 
Females reported more problems managing their diet. Race, time on dialysis and perceived 
income adequacy did not appear to influence outcome measures (Clark-Cutaia et al., 
2014). 
A longitudinal study with one month of follow-up carried out in Brazil aimed to describe 
the prevalence of adherence to fluid restriction using daily IDWG. The study included 146 
patients, and the results showed that adherence to fluid restriction was 61% (Molto et al., 
2012). 
A correlational study carried out in Iran aimed to identify degree of adherence to dietary 
and fluid restrictions among HD patients. The sample of the study consisted of 273 
patients. The results showed that mean IDWG was 1.49 kg, mean serum K
+
 was 4.76 
MEq/l, mean serum PO4 was 6.37 mg/dl, and the results indicated that most of the patients 
have a moderate rate of nonadherence to dietary and fluid restrictions (Ahrari et al., 2014). 
It is important to mention that the IDWG reflects also nutritional intake, which is necessary 
for growth, but dietary intake should not be reduced in an attempt to achieve a safe 
ultrafiltration rate (Huang et al., 2014). Thus, the researcher believes that it is essential to 
follow a dietary regime that maintains body weight, maintains BP within target level to 
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avoid undesired complications that may results because of fluid intake and dietary 
disturbances.  
2.2.6 Adherence to treatment program in pediatric CKD 
Chronic kidney disease is a prolonged illness, which need different aspects of management 
including HD, strict dietary regime, and fluid restriction, in addition to taking some 
medication that are prescribed by the physician. Consequently, this leads to a greater 
personal and financial burden on the patient and his family. Adherence to treatment is the 
degree to which individuals stick to the medical advice given to them for the purpose of 
treatment (Beerendrakumar et al., 2018).   
Management of CKD requires a complex therapeutic regimen, including hemodialysis and 
a strict regimen of medication, diet and fluid control (Lins et al., 2018). In my opinion,due 
to the irreversible nature of the disease, CKD pediatric patients have to make adaptations 
and modifications in their life including diet, fluid restriction, and following medical 
instructions and HD program to avoid complications or deterioration in their condition that 
may occur because of non-adherence to treatment program. 
Previous studies reported variations in degree of adherence / non-adherence to different 
aspects of treatment regime. Magacho et al., (2011) reported that 26% to 28% of CKD 
pediatric patients were non-adherent to medication prescribed by their physician.  
In some studies, adherence to treatment was measured by using serum electrolytes 
including serum K
+
 and serum PO4 or serum BUN. PO4 was the most common indicator of 
dietary nonadherence (Huang et al., 2014). An observational, cross-sectional study carried 
out in Kentucky, USA aimed to examine fluid and dietary adherence in 100 patients with 
ESRD receiving HD, found that 50% of the HD patients were nonadherent to PO4 
restrictions and they relate a high prevalence of non-adherence to lack of knowledge about 
dietary PO4. Lack of knowledge about foods that contain PO4 and culture-related norms 
likely made adherence to this restriction difficult. In addition, patients may have been more 
likely to adhere to K
+
 restriction because hyperkalemia is associated with life threatening 
cardiovascular complications such as fatal dysrhythmias. The prevalence of elevated K
+
 
and BUN was low 10% and 1% respectively (Khalil et al., 2011).  
A case control study conducted at the Nephrology Department of Abd El-Aziz El-Rantesy 
Specialized Pediatric Hospital in GS. The sample of the study consisted of 112 subjects (60 
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CKD pediatric patients and 52 healthy control individuals), their age ranged between 1 – 
12 years. The results showed that there was a significant relationship between HTN and 
CKD among pediatric patients. There was significant increase in the SBP and DBP in the 
pediatric patients as compared with the controls. In addition, patients showed significantly 
higher levels of BUN and creatinine. The results also indicated that pediatric patients had 
significantly lower calcium and higher PO4 as compared with controls (Muhaisen et al., 
2012).  
A cross-sectional study carried out at An-Najah National University Hospital in WB aimed 
to assess adherence to diet, fluid restriction, medications, and HD sessions. Self-reported 
adherence behavior obtained using ESRD Adherence Questionnaire. Predialytic serum 
levels of K
+
 and PO4 were obtained as clinical indicator of diet and medication adherence 
respectively. In addition, interdialytic body weight (IDW) was also obtained from medical 
records and analyzed in relation to reported adherence of fluid restriction.The results of the 
study showed that dietary adherence was observed in 24% of patients, while adherence to 
fluid restriction was observed in 31% of patients. Reported adherence to HD sessions was 
52% while adherence to medications was 81%. Overall, 55.5% patients had good 
adherence, 40.5% had moderate adherence, and 4.1% had poor adherence behavior. Male 
patients had significantly higher overall adherence scores than females (P = 0.034). A 
significant correlation between reported diet adherence and pre-HD serum K
+
 level (p < 
0.01) was observed. A significant correlation between reported fluid restriction adherence 
and IDW (p < 0.01) was also found (Naalweh et al., 2017). 
A comprehensive systematic review study aimed to identify factors associated with 
nonadherence to medication therapy in patients undergoing HD. The study results showed 
that the prevalence of medication nonadherence varied from 12.5% to 98.6%. Most 
common factors significantly associated with nonadherence were younger age, non-
Caucasian ethnicity, and illness interfering family life, being a smoker, and being single, 
divorced or widowed. Similarly, disease-related factors included duration of HD, recurrent 
hospitalization, having diabetes and hypertension. Medication-related factors such as daily 
tablet count, total pill burden, and complexity of medication regimen were also associated 
with poor adherence (Ghimire et al., 2015).  
Another descriptive study carried out in Turkey aimed to determine adherence to diet and 
fluid restriction among patients on HD. The study included 154 patients, and the results 
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showed that 98.3% of patients were not adherent to their prescribed diet, 95% were not 
adherent to fluid restriction, and they were found to have IDWG of 3 – 4.4 kg (Efe and 
Kocaoz, 2015).  
A prospective, cross-sectional study carried out in India aimed to evaluate adherence to 
medication, and study factors associated with non-adherence in CKD patients. The study 
included 150 CKD patients, and the results showed that 34% of patients were non-adherent 
to prescribed medication schedule whereas 37.33% patients showed low adherence in 
Morisky medication adherence scale (MMAS). Investigation of causes of non-adherence 
reflected that 21.3% of patients attributed non-adherence due to high cost of medication, 
20% due to complex dosing schedule, 16% due to fear of adverse effects. Moreover, the 
results revealed that 68% of patients were not aware about the importance of taking each 
medicine (Sontakke et al., 2015). 
A cross sectional study carried out in India aimed to determine level of adherence to the 
dietary and fluid restriction among CKD patients. The sample of the study consisted of 100 
CKD patients, and the results showed that 20% of patients had mild deviation and 69% of 
them had moderate deviation from dietary restrictions guidelines. In addition, the results 
showed that 69% of patients had moderate deviation, and 22% had mild deviation from 
fluid restriction guidelines. Moreover, there was no association between age and sex and 
adherence level, while patients education was associated with level of adherence as 
illiterate patients were more deviated from guidelines (Beerendrakumar et al., 2018).  
A descriptive and cross-sectional study carried out in Brazil aimed to assess the adherence 
of CKD patients to the four dimensions of the therapeutic regimen: hemodialysis, 
medication use, diet and fluid restriction. The sample of the study consisted of 78 CKD 
patients on HD for more than three months. The results showed that 68% of pediatric 
patients expressed adherence to HD, 93.6% expressed adherence to medication, 82.1% 
were adherent to fluid restriction, and 85.9% were adherent to diet (Lins et al., 2018).  
In Ethiopia, a cross sectional study carried out to assess the management practice, 
medication adherence, and factors affecting medication adherence in CKD patients. The 
sample of the study consisted of 256 CKD patients recruited through systematic random 
sampling. Data were collected from medical records and interviewing patients. The rate of 
adherence was determined using 8-item Morisky medication adherence scale. The results 
showed that 61.3% (stages 1 and 2=70%, stage 3=73.9%, stage 4=54.5%, and stage 
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5=43%) of the study population were adherent to their treatment regimens. Forgetfulness 
(79.8%) was the major reason for medication nonadherence (Kefale et al., 2018). 
2.2.7 Burden of nonadherence to treatment in CKD pediatric patients 
Chronic Kidney Disease is a public health problem worldwide. CKD involves the patients 
and their families because it requires behavioral changes including changes in lifestyle, and 
changes in dietary and fluid intake (Barnett et al. 2008). Therefore, to treat these patients 
successfully, adherence to complex treatment program including diet, fluid, and HD is 
essential. On the other hand, nonadherence to diet and fluid restrictions may lead to 
accumulation of metabolic by-products and excess fluid in the circulatory system, leading 
to increased morbidity and mortality for CKD patients. CKD, especially if it develops early 
in life, leads to significant height stunting and disproportionate growth failure. The height 
deficit begins as early as the first postnatal months, with a cumulative height deficit of -3 
standard deviations by 3 years of age (Kaspar et al., 2016).  
Low or nonadherence to dietary regime is a significant health problem that reduces the 
benefits of treatments, exacerbates symptoms, reduces quality of life for the patient, as well 
as increasing costs to both the patient and the health system (Ahrari et al. 2014).  
In GS, with scarce resources and high poverty rate caused by the long-term siege, the 
situation is very difficult for MOH and the families of the pediatric patients. From my 
experience in dialysis units, there is shortage of the intravenous solutions for dialysis, 
which put the life of pediatric patients with CKD at risk. In addition, the number of dialysis 
machines designed for children is about 15 machines which is inadequate compared to the 
number of patients (50 pediatric patients), and the number is increasing steadily. In 
addition, pediatric patients with CKD should come to the hospital 3 to 4 times per week for 
HD, and that is consuming for the patient and his parents, as many families cannot afford 
to pay for that. In addition, school-age children will be away from school and that will 
affect their school achievement.  
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3 Chapter Three 
Methodology 
3.1 Study design 
This study utilized a cross-sectional design. This design is appropriate for describing the 
status of phenomena (adherence to diet, fluids, and medication), and for describing 
relationships between phenomena (relationship between BP and diet, fluid, and 
medication). Furthermore, cross-sectional involves the collection of data about the 
phenomena under study during a single period of time (Polit and Beck, 2012).  
3.2 Setting of the study 
The study was carried out in hemodialysis units at governmental hospitals in the Gaza 
Strip, namely Al Shifa Medical Complex, Nasser Medical Complex, Al Aqsa hospital, Al 
Najar hospital, and Al Rantesy Specialized Pediatric Hospital. 
3.3 Population and sample of the Study 
The population for the study consisted of all the children with CKD undergoing 
hemodialysis in the governmental hospitals in the Gaze Strip (Al Rantesy, Nasser, Shohada 
Al Aqsa, and Al Najar hospital). The total number of children with CKD was 49 patients. 
The sample of the study consisted of 43 children with CKD and undergoing to 
hemodialysis (census). The response rate was 87.7% as presented in table (3.1).  
Table (3.1):Distribution of study participants by hospital 
Hospital  Frequency Percent 
Al Najar 2 4.7 
Nasser 5 11.6 
Shohada Al Aqsa 1 2.3 
Al Rantesy 35 81.4 
Total  43 100.0 
3.4 Period of the study 
The study commenced from January 2018 to March 2019. Data collection took place from 
April to July 2018.  
20 
 
3.5 Eligibility criteria 
3.5.1 Inclusion criteria 
- Children with CKD aged ≤18 years. 
- On hemodialysis. 
3.5.2 Exclusion criteria 
- Patients with history of mental illness.  
3.6 Instruments of the study 
After reviewing literature and previous studies, the researcher developed a questionnaire 
for data collection. The questionnaire consisted of the following parts: (Annex 2) 
- Sociodemographic characteristics of study participants: (child gender, age, 
educational level, place of residency, hospital, family income, fathers' education, and 
mothers' education). Number of HD sessions per week, years of being on dialysis, 
weight. Medical history of the participants (presence of hypertension, cardiac disease, 
Diabetes mellitus, number of years on HD, number of HD sessions per week, number 
of hours per session, type of dialysis machine). 
- Adherence to diet: measured by serum K+, serum PO4, Blood Urea Nitrogen – BUN. 
(Non-adherence to the diet defined as the presence of at least one of the following: 
serum K
+
> 5.5 mg/dl, serum PO4> 5.5 mg/dl or serum BUN > 100 mg/dl). 
- Adherence to fluid restriction: measured by IDWG, and calculated by subtracting the 
child's weight upon the arrival to the dialysis unit from the weight at the end of 
previous HD session. (Non-adherence to fluids defined as IDWG > 2.5 kg) (Olivera et 
al., 2015). 
- Measurement of Blood Pressure: BP measured by electronic device attached to the 
dialysis machine. BP is recorded three times each session; at the beginning of the 
session, at mid of the session, and at the end of session (the Child is considered 
hypertensive if his or her BP is more than 140/90 mmHg before dialysis or more than 
130/ 80 mmHg after dialysis). 
- Role of the nurse in monitoring adherence to diet, fluid restriction, and 
medication: The questionnaire consisted of 19 statements, scores for responding to 
each statement was yes (2) and no (1) for positive statement, and yes (1) and no (2) for 
negative statements.  
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- Adherence to medication: To determine adherence to medication, the researcher 
adopted Morisky Medication Adherence Scale (MMAS)(Morisky et al., 2008). 
Morisky Medication Adherence Scale consists of 8 items. Seven questions have 
response on yes/no, and one question has a response on a 4-point Likert scale which is 
(0 = Never, 1= rarely, 2= Sometimes, 3= always). According to the scoring system for 
the MMAS, the score zero indicate high adherence, 1 – 2 indicate medium adherence, 
and 3 – 8 indicate low adherence. 
3.7 Pilot study 
a. Face and content validity 
To examine validity, suitability and clarity of the questionnaire items, the researcher 
distributed the questionnaire to a panel of experts (Annex 3) for reviewing the 
questionnaire, and their comments were considered in modifying the questionnaire. 
b. Reliability 
A pilot study carried out on 20 CKD children to check its reliability by using Cronbache 
alpha method. The results indicated that the questionnaire was reliable as presented below. 
Table (3.2): Overall scores of the questionnaire (Cronbache alpha) 
Scale  No. of items Alpha value 
The role of the nurse working in hemodialysis unit in 
monitoring the adherence to diet, fluid, and medication. 
19 0.799 
3.8 Data Collection 
Data collection included the following steps:  
- Recruitment of the pediatric patients based on the eligibility criteria.   
- The researcher explained the purpose of the study for the child / his or her parents, and 
then obtained their consent and agreement to participate in the study.  
- Filling the questionnaire through interview with the children and or their parents. 
3.9 Study procedures 
Blood pressure measurement: The researcher measured BP for each participant on three 
consecutive HD sessions. Each session, the researcher recorded BP on two phases (pre-
dialysis and 15 minutes post-dialysis). 
Body weight measurement: The researcher measured body weight for each participant on 
three consecutive sessions. Each session, the researcher recorded body weight on two 
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phases (pre-dialysis and immediately post-dialysis). IDWG measured by subtracting pre-
dialysis body weight from body weight at the end of the previous session. 
Serum K
+
, PO4 and BUN: The researcher draw blood sample for each participant on three 
consecutive sessions. Each session, the researcher recorded levels of serum K
+
, PO4 and 
BUN on two phases (pre-dialysis and at the end of previous session). 
3.10 Data entry and analysis 
For data entry, the researcher used SPSS program (version 22). Data entry and analysis 
included the following steps: Coding design for data entry, then data cleaning, followed by 
performing descriptive analysis including frequencies, means, standard deviation, and 
percentage. In addition, performing inferential analysis using T test, One way ANOVA, 
and Pearson correlation test. 
3.11 Ethical and administrative considerations 
Before carrying out the study, the researcher got approval from Al-Quds University. Then 
the researcher obtained approval letter from Helsinki Committee (Annex 4), and MOH 
(Annex 5). The subjects were informed that participation in the study is voluntary and the 
patients have the right to refuse the participation or withdraw from the study at any time. 
The researcher assured the participants that he would use data for research purposes only. 
The researcher obtained consent from each participant before data collection (annex 1). 
3.12 Limitation of the study 
The researcher faced difficulties in controlling for potentially confounding biochemical 
factors that might have influenced serum potassium, phosphorus and urea levels. In 
addition, the researcher faced difficulties in controlling for potentially confounding and 
isolation the effects of the socio-behavioral variables associated with adherence. 
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4 Chapter Four 
Results and Discussion 
4.1 Descriptive results 
The sample of the study consisted of 43 children with CKD, on HD from GS. The 
characteristics of study participants presented below. 
4.1.1 Sociodemographic characteristics of study participants 
 
Figure (‎4.1): Distribution of study participants by gender 
  
Figure (2.1) showed that 30 (69.8%) of study participants were male children and 13 
(30.2%) were female children. This result was consistent with Harambat et al., (2012) who 
reported that the incidence and prevalence of pediatric CKD is greater in males than 
females because of the higher frequency of congenital abnormalities of the kidney and 
urinary tract in males.  
 
 
 
Male 
30 (69.8)
Female 
13 (30.2)
24 
 
Table (4.1): Sociodemographic characteristics of the study participants (n=43) 
Variable  Frequency Percent 
Age of child 
≤12 years  
 
20 46.5 
> 12 years  
 
23 53.5 
Total  43 100.0 
Mean age= 11.78±4.52 years 
Level of education 
Preschooler  13 30.2 
Primary school 19 44.2 
Preparatory school 6 14.0 
Secondary school  5 11.6 
Total  43 100.0 
Place of residency 
South area  16 37.2 
Middle area  4 9.3 
Gaza and north 23 53.5 
Total  43 100.0 
Hospital  
Al Najar 2 4.7 
Nasser 5 11.6 
Shohada Al Aqsa 1 2.3 
Al Rantesy 35 81.4 
Total  43 100.0 
 
Table (4.1) showed that 20 (46.5%) of pediatric patients aged 12 years and less and 23 
(53.5%) aged more than 12 years, their mean age was 11.78±4.52 years. Moreover, 19 
(44.2%) of study participants had primary school education and 13 (30.2%) were 
preschoolers. In addition, 23 (53.5%) were from Gaza governorate and north of Gaza, 16 
(37.2%) were from the southern governorates, and 4 (9.3%) from the middle governorate. 
Moreover, 35 (81.4%) received HD at Al Rantesy hospital, 5 (11.6%) received HD at 
Nasser hospital, and 2 (4.7%) received HD at Al Najar hospital. 
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Table (4.2): Family characteristics (n=43) 
Variable  Frequency Percent 
Fathers' education 
Preparatory school and less 17 39.5 
Secondary school 11 25.6 
University  15 34.9 
Total  43 100.0 
Mothers' education 
Preparatory school and less 15 34.9 
Secondary school 18 41.9 
University  10 23.2 
Total  43 100.0 
Family income 
Less than 1832 NIS 40 93.0 
1832 NIS and more 3 7.0 
Total  43 100.0 
Mean income= 816.27   SD= 631.67 NIS 
                 NIS= New Israeli Shekel 
Table (4.2) showed that 17 (39.5%) of fathers had low education preparatory school and 
less, 15 (34.9%) of fathers had university education, while 11 (25.6%) of fathers had 
secondary school education. Furthermore, 18 (41.9%) of mothers had secondary school 
education, 15 (34.9%) had preparatory school education and less, and 10 (23.2%) of 
mothers had university education. These results reflected that the majority of parents had 
low education of secondary school and less.In addition, 40 (93.0%) of families have 
monthly income of less than 1832 NIS (poverty line according to PCBS), and only 3 
(7.0%) had an income of 1832 NIS and more. So, we can conclude that there is as 
association between parents’ level of education, family income and the prevalence of 
ESRF.  
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4.1.2 Medical characteristics of study participants 
Table (4.3): Medical characteristics of the study participants (n=43) 
Variable Frequency Percent 
Hypertension  
Yes  38 88.4 
No  5 11.6 
Heart Diseases 
Yes  10 23.3 
No  33 76.7 
Diabetes Miletus type I 
Yes  0 0 
No  43 100.0 
Other disease(s) 
Yes  10 23.3 
No  33 76.7 
Table (4.3) showed that 38 (88.4%) of study participants had hypertension, 10 (23.3%) had 
heart disease, none of them had Diabetes type I, and 10 (23.3%) had other diseases such as 
asthma, and chronic chest infections. 
This result indicated that the majority of pediatric CKD patients have HTN. This result was 
consistent with Kramer et al., (2011) who reported that HTN is highly prevalent in 
pediatric CKD patients. In addition, Agarwal et al., (2014) reported that 76% of pediatric 
CKD patients on chronic dialysis had HTN, while other studies reported that about 50% of 
pediatric CKD patients had HTN (Samuels et al., 2012; Mitsnefes, 2012). These result 
reflected that HTN is highly prevalent among pediatric CKD patients.  
Table (4.4): Information about dialysis (n=43) 
Variable Mean  SD Min-Max value 
Years of dialysis 3.73 year 2.26 year 6 months – 8 years 
Sessions per week 
 
2.69 session 0.96 session 1 – 4 sessions 
Hours per session  3.74 hours 0.44 hour 3 – 4 hours 
Emergency dialysis per month 1.11 time 1.21 time 0 – 4 times 
Table (4.4) showed that the study participants have been on hemodialysis for 6 months to 8 
years with mean 3.73±2.26 years. Number of sessions ranged between 1 – 4 sessions per 
week with mean 2.69±0.96 session per week. Duration of each session ranged between 3 – 
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4 hours with mean 3.74±0.44 hours per session. Emergency dialysis ranged from 0 – 4 
times per month with mean 1.11±1.21 times per month.   
4.2 Adherence to diet, fluid, and medication 
The researcher examined adherence to diet by testing serum levels of K
+
, PO4, and BUN. 
The researcher tested each parameter three times before dialysis sessions then the 
researcher calculated the mean level for each parameter. The researcher examined 
adherence to fluids intake by body weight in two phases (pre-dialysis and post-dialysis) 
and target weight was calculated. Body weight has been measured three times (each 
session), and then the mean weight has been calculated as presented in table (4.5). 
Table (4.5): Adherence to diet and fluids (n=43) 
Indicator Mean SD Min Max 
Adherence 
indicator 
Diet parameters 
Pre-dialysis serum potassium (K
+ 
mg/dl) 5.49 0.77 4.27 7.27 < 5.50 
Pre-dialysis serum phosphorous (PO4 
mg/dl) 
6.52 1.98 2.67 11.83 < 5.50 
Pre-dialysis serum (BUN mg/dl) 161.04 52.42 55.33 292.0 < 100.0 
Fluids intake parameters (Wt. Kg) 
Weight upon arrival for sessions (pre-
dialysis) 
25.10 9.51 3.53 49 - 
Weight at the end of sessions (post-
dialysis) 
23.37 8.96 3.27 46 - 
IDWG (kg)  1.73 0.55 0.10 3.83 < 2.50 
Table (4.5) showed indicators that reflect adherence to diet and fluids. The results showed 
that the pre-dialysis serum K
+
 ranged from 4.27 to 7.27 mg/dl with mean 5.49±0.77 mg/dl. 
Pre-dialysis serum PO4 ranged from 2.67 to 11.83 mg/dl with mean 6.52±1.98 mg/dl. Pre-
dialysis serum BUN ranged from 55.33 to 292.0 mg/dl with mean 161.04±52.42 mg/dl. 
These results indicated poor adherence to diet as mean serum K
+
 was at borderline and the 
mean of serum PO4 and BUN were high. Indicators for adherence to fluids showed that 
IDWG ranged from 0.10 kg to 3.83 kg with mean IDWG 1.73±0.55 kg.   
As presented in our results, it is clear that there was no control of diet as indicated by the 
levels of K+, PO4, and BUN. This result is explained in the context that high K
+
 content 
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presents in fruits, and people in Gaza do not eat much fruits on daily basis and if they eat 
fruits, they usually eat small amount of fruits. On the other hand, PO4 present in many 
foods such as meat products, dairy products, eggs and processed foods, and these foods are 
eaten almost every day, which in turn lead to elevation of serum PO4 in the blood. 
Controlling phosphate intake was also challenging for most patients. Nearly matched 
results obtained by Beerappa and Chandrababu (2019)who found that 65% of study 
participants have good adherence to dietary K
+
(mean pre-dialysis serum K
+
 5.0±0.76 
mEq/L), 68.3% of participants had serum phosphate level in the range of 2.5 - 4.5 mg/dL 
with mean 3.27 ± 0.98 mg/dL, and the total mean IDWG of the participants was 1.40 ± 
0.37 kg. Furthermore, Ibrahim et al., (2015) found that IDWG and serum PO4 were 
significantly high. In addition, the results of Ahrari et al., (2014) matched with our results, 
which showed that mean serum K
+
 was 4.76 mg/l, mean serum PO4 was 6.37 mg/dl, and 
mean IDWG was 1.49 kg.  
Table (4.6): Participants’ response on Morisky Medication Adherence Scale (n=38) 
Response  
Item No 
n (%) 
Yes 
n (%) 
21 (55.3) 17 (44.7) 1. Do you forget sometimes to take anti-hypertensive 
medication? 
24 (63.2) 14 (36.8) 2. In the last two weeks, did you forget to take anti-
hypertensive medication? 
28 (73.7) 10 (26.3) 3. Did you stop taking your anti-hypertensive medication 
without informing your physician, because you feel 
unpleasant when taking the medication? 
3 (7.9) 35 (92.1) 4. When you go out or travel, do you sometimes forget 
(without intension) to take your anti-hypertensive 
medication with you?  
9 (23.7) 29 (76.3) 5. Did you take your anti-hypertensive medication yesterday? 
(*) 
22 (57.9) 16 (42.1) 6. When you feel that your BP is controlled, do you 
sometimes stop taking your anti-hypertensive medication? 
9 (23.7) 29 (76.3) 7. Did you feel one-day that you were disturbed from taking 
anti-hypertensive medication? 
17 (44.7) 21 (55.3) 8. Do you have difficulty remembering to take all your 
medication? 
Overall mean score = 4.50±1.84 
(*) reversed statement 
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Table (4.6a) showed that 35 (92.1%) sometimes forgot to take their antihypertensive 
medication when they go out or travel, 29 (76.3%) felt one-day that they were disturbed 
from taking antihypertensive medication, 29 (76.3%) said that they took their 
antihypertensive medication yesterday. In addition, 17 (44.7%) forget sometimes to take 
their anti-hypertensive medication, and 16 (42.1%) sometimes stop taking their anti-
hypertensive medicationwhen they feel that their BP is controlled. Generally, the results 
indicated low adherence to antihypertensive medication among CKD patients with mean 
score 4.500±1.841.  
Table (4.6b): Adherence to medication among study participants (n=38) 
Level of adherence Score n percent 
High Zero 0 0 
Medium 1 – 2 6 15.8 
Low 3 - 8 32 84.2 
Table (4.6b) showed that the majority of children 32 (84.2%) have low adherence to 
medication and 6 (15.8%) of them have medium adherence to medication. Similar results 
obtained by Minutolo et al., (2011) who found that the prevalence of medication 
nonadherence varied from 12.5% to 98.6%.  
Inconsistent results obtained bya study carried out in India showed that 34% of patients 
were non-adherent to prescribed medication schedule whereas 37.33% patients showed 
low adherence in Morisky medication adherence questionnaire (Sontakke et al., 2015). 
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Table (4.7): Role of the nurses working in hemodialysis units in monitoring adherence 
of pediatric patients to fluid, diet, and medication 
No. Item 
Yes 
n (%) 
No 
n (%) 
1.  Are your blood pressure taken by the nurse during dialysis session three 
times? 
34 (79.1) 9 (20.9) 
2.  Does the nurse measure your weight before dialysis session? 
37 (86.0) 6 (14.0) 
3.  Does the nurse measure your weight after dialysis session? 
37 (86.0) 6 (14.0) 
4.  Have you received instructions regarding food during dialysis? 
40 (93.0) 3 (7.0) 
5.  Are the nurses advising the patients or their parents about the correct time 
of medications before dialysis session? 
35 (81.4) 8 (18.6) 
6.  Are the nurses advising the patients or their parents about the correct time 
of medications after dialysis session? 
35 (81.4) 8 (18.6) 
7.  Do the nurses make check for the patient weight at the end of dialysis? 
40 (93.0) 3 (7.0) 
8.  Do you receive instructions by the nurses to avoid excessive drinking 
water during dialysis? 
41 (95.3) 2 (4.7) 
9.  Did the nurse tell you about the amount of fluid which is allowed during 
the day? 
38 (88.4) 5 (11.6) 
10.  Did the nurse tell you about the type of food which is allowed during the 
day? 
40 (93.0) 3 (7.0) 
11.  Did the nurse tell you about the amount of food which is allowed during 
the day? 
39 (90.7) 4 (9.3) 
12.  Did the nurse inform the patient and /or the parents that the weight 
between the sessions; should not be more than the 5% of overall weight? 
36 (83.7) 7 (16.3) 
13.  Did the nurse tell the patients and /or the parents that the increase in the 
dry weight based on the child's growth and age? 
41 (95.3) 2 (4.7) 
14.  Have you been advised by the nurse about the importance of adherence to 
diet to prevent complications? 
43 (100.0) 0 (0.0) 
15.  Have you been advised by the nurse about the importance of adherence to 
fluids to prevent complications? 
43 (100.0) 0 (0.0) 
16.  Have you been advised by the nurse about the importance of adherence to 
medications to prevent complications? 
43 (100.0) 0 (0.0) 
17.  Did the nurse tell you about the correct time of taking your drugs after 
dialysis session? 
42 (97.7) 1 (2.3) 
18.  Did the nurse teach you about the complications of the disease, diet, 
fluids intake and medications for the patient and parents? 
43 (100.0) 0 (0.0) 
19.  Did the nurse teach you about the time of taking medications? 
39 (90.7) 4 (9.3) 
Overall mean score = 1.913      Weighted percentage = 95.65 
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Table (4.7) showed that all the study participants (100%) said that the nurses advised them 
about the importance of adherence to diet, fluids, and medication. Furthermore, all the 
study participants (100%) said that the nurses taught them about the complications of the 
disease, diet, fluid intake, and medication. In addition, 42 (97.7%) of study participants 
mentioned that the nurses tell them about the correct time of taking medication after 
dialysis session. While 34 (79.1%) of study participants stated that the nurses check BP 3 
times during dialysis session. In general, the results indicated that the nurses showed high 
level (95.65%) of monitoring the adherence of their patients concerning diet, fluid intake, 
and medication.  
In my opinion, nurses in the dialysis unit play an important role in monitoring adherence of 
their patients to the treatment program. They are measuring their body weight, BP, and 
checking their serum levels of electrolytes and BUN every time they are coming for HD. 
Therefore, they are in a position to closely monitor and observe any deviation occurred in 
their patients. In addition, they have adequate time to set with their patients during dialysis 
to assess their diet and fluid intake, they can inform them about type of foods allowed and 
which foods are not permitted. In addition, they can inform them about amount and type of 
fluids that they can drink. By doing that, the nurses can fulfill their role in assessing, 
monitoring and educating their patients about proper ways to maintain good adherence to 
treatment, and avoid complications and progression of the disease.  
Table (4.8) Summary of adherence to diet, fluids, medication, and role of the nurse in 
hemodialysis 
Item 
Adhered 
n (%) 
Not adhered 
n (%) 
Mean ±SD 
Diet  3 (7.0) 40 (93.0) - 
Fluids  38 (88.4) 5 (11.6) - 
Medications 14 (36.8) 24 (63.2) 4.500±1.841 
Role of the nurses in monitoring the 
adherence of pediatric patients to diet, fluid 
intake, and medication. 
40 (93.0) 3 (7.0) 1.913±0.128 
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Table (4.8) showed that 3 (7%) of study participants were fully adhered to diet, 38 (88.4%) 
were fully adhered to fluids intake, and 14 (36.8%) were fully adhered to anti-hypertensive 
medication. In addition, 40 (93%) of study participants reported that the nurses were fully 
performing their role in monitoring the adherence of patients to diet, fluids intake, and 
medication.   
Nearly matched results obtained by Nerbass et al., (2010) who found that 61% of patients 
reported lack of adherence to dietary recommendations. In addition, Nerbass et al., (2017) 
more recent study by the same researchers found that the prevalence of patients with high 
% IDWG (> 4.5% of DW) and hyperkalemia is around 30%, while of hypophosphatemia is 
even higher (around 45%), and almost 58% of the patients had a salt intake over 
recommendation ().  
On the other hand, better results obtained by Niraj et al., (2018)who found that 20% of 
patients had mild deviation and 69% had moderate deviation from dietary restrictions,also 
69% had moderate deviation, and 22% of them had mild deviation from fluid 
restriction.Moreover, Magacho et al., (2011) have reported that 26% to 28% of CKD 
patients were non-adherent to medication prescribed by their physicians. Naalweh et al., 
(2017) found that dietary adherence observed in 24% of patients, adherence to fluid 
restriction observed in 31% of patients, adherence to HD sessions was 52%, adherence to 
medications was 81%, and overall, 55.5% patients had good adherence, 40.5% had 
moderate adherence, and 4.1% had poor adherence behavior. Another study carried out in 
Brazil showed that 68% of patients expressed adherence to HD, 93.6% expressed 
adherence to medication, 82.1% were adherent to fluid restriction, and 85.9% were 
adherent to diet (Lins et al., 2018). 
Poor adherence found by Efe and Kocaoz (2015) who reported that 98.3% of patients were 
not adherent to prescribed diet, 95% were not adherent to fluid restriction, and they have 
IDWG of 3 – 4.4 kg.  
Our results indicated good adherence to fluid intake and low adherence to diet and 
medication. This result raised the need for more attention from healthcare providers and 
parents on methods to improve adherence to diet and medication to avoid deterioration of 
the health condition of those patients resulted from poor adherence.  
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Table (4.9) Status of blood pressure before and after dialysis (n=43) 
Blood 
Pressure 
(mmHg) 
Pre-dialysis Post-dialysis Overall 
Mean ± 
SD 
Min - Max 
Mean ± 
SD 
Min - Max Mean ± SD Min - Max 
Systolic BP 
(SBP) 
129.66±19.50 93.67-176.67 111.55±19.64 83.33-175.67 120.61± 18.82 91.00 – 171.00 
Diastolic BP 
(DBP) 
78.58±13.52 55.33-110.00 68.08±14.95 47.33-121.67 73.33±13.61 51.33 – 112.00 
Table (4.9) presented description of BP findings. The results showed that the mean SBP at 
pre-dialysis phase was 129.66±19.50 mmHg and at post-dialysis phase was 111.55±19.64 
mmHg, the mean DBP at pre-dialysis phase was 78.58±13.52 mmHg and at post-dialysis 
phase was 68.08±14.95 mmHg.These results showed considerable differences between 
systolic and diastolic BP which caused by fluid accumulation between sessions. HTN is a 
common manifest among CKD patients. Therefore, measurement and control of BP is 
necessary step in the management of these patients. A study carried out in Gaza found 
significant increase in the SBP and DBP in HD patients (Muhaisen et al., 2012).  
Table (4.10): Correlation between blood pressure and adherence to diet, fluids, 
medication, and role of nurses in monitoring adherence (n=43)
 
Variable 
SBP (mmHg) DBP (mmHg) 
r p-value r p-value 
Diet 
K
+ 
mg/dl -0.168 0.281 -0.048 0.760 
PO4 mg/dl -0.237 0.125 -0.248 0.109 
BUN mg/dl -0.280 0.069 -0.364 0.016 * 
Fluids (IDWG) 0.291 0.058 0.431 0.004 * 
Medication - Morisky score -0.142 0.396 -0.205 0.217 
Role of the nurses in 
monitoring the adherence 
-0.141 0.367 -0.130 0.406 
r= correlation 
* Significant at the 0.05 level. 
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Table (4.10) showed that there is a statistically significant inverse correlation between 
DBP and BUN (r= -0.364, P= 0.016), and there was a statistically significant positive 
correlation between DBP and fluid intake (r= 0.431P= 0.004). While there is no statistical 
significant correlation between SBP and adherence to diet (K
+
, PO4, BUN), fluids, 
medication, and role of nurses in monitoring adherence.  
The researcher believes that patients with CKD needs to modify their lifestyle, focusing on 
diet and fluid intake as the prognosis of these patients largely depends on adherence to the 
recommended nutritional regime. Nonadherence to the suggested diet and fluids regime 
leads to rapid worsening of the condition. Elevation of BP is one of the main complications 
associated with CKD, thus, adherence to diet, fluid intake, and medication is essential to 
control BP.  
Table (4.11): Correlation between diet, fluid, medication adherence and role of 
nurses’monitoring in adherence 
Variable 
Diet Fluids Medication 
r p value r p value r p value 
Fluids 0.42 0.510 - - - - 
Medications -2.06 0.042* 1.220 0.222 - - 
Role of nurses’ in 
monitoring 
adherence. 
-0.490 0.620 -0.040 0.961 -0.160 0.320 
r= correlation – Pearson test    * Significant at the 0.05 level. 
Table (4.11) showed that there was statistically significant correlation between diet and 
medication (P= 0.04), but there is no statistical significant correlation between diet and 
fluids and role of the nurse in monitoring adherence (P= 0.51 and 0.62 respectively). Koc 
et al., (2011) found positive relationship between IDWG and elevated BP. In addition, the 
results of Paglialonga et al., (2015) indicatedpositive relationshipbetween IDWG and 
elevated BP. Another study carried out in WB reported significant correlation between diet 
adherence and serum pre-HD K
+
 level, and significant correlation between fluid restriction 
adherence and IDW (Naalweh et al., 2017). 
It is important to say that diet, fluids, and medication are independent factors that are 
important components of treatment program for CKD patients. Even though the results did 
not show significant correlation between the three factors but they are collectively vital for 
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the progression of the disease and avoiding complications that may encounter because of 
nonadherence to these factors. 
Table (4.12): Correlation between blood pressure and selected variables 
Variable 
SBP (mmHg) DBP (mmHg) 
r p-value r p-value 
Age (years) 0.26 0.091 0.27 0.081 
Family income (NIS) -0.15 0.302 -0.05 0.710 
Number of years on dialysis 0.20 0.188 0.19 0.203 
Session/week 0.17 0.270 0.26 0.091 
Hours/session -0.50 0.001* -0.47 0.001* 
Emergency dialysis 
(time/month) 
0.05 0.742 -0.02 0.880 
r= correlation     * Significant at the 0.05 level 
Table (4.12) showed that there was statistically significant inversed correlation between 
SBP, DBP and number of hours per HD session (P= 0.001), which means that longer hours 
of dialysis will lead to lower SBP and DBP. Inconsistent results obtained by Clark-Cutaia 
et al., (2014) who foundno relationship betweenhours of dialysis sessionandBP for patients 
with CKD. 
In my opinion, if the patient stayed longer hours on the HD, the patient will lose more 
fluids and other substances, and as a result his BP will be lower and he will lose more 
weight. Because the dialysis unit in Al Rantesy hospital is the only one that serve pediatric 
patients with CKD in GS, usually the patients do not stay on HD for more than three hours 
per session. There are 14 machines in the unit serving all the 50 pediatric patients, and that 
caused pressure on the machines and nurses who are working in the unit. 
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Table (4.13): Differences in adherence related to gender of child (N= 43) 
Variable Gender n Mean SD t P value 
SBP 
Male 30 129.177 20.417 
-0.247 0.806 
Female 13 130.794 17.933 
DBP 
Male 30 78.088 13.917 
-0.359 0.721 
Female 13 79.717 13.045 
Serum K
+
 
Male 30 4.238 0.599 
-0.593 0.557 
Female 13 4.362 0.697 
Serum PO4 
Male 30 6.493 1.837 
-0.160 0.874 
Female 13 6.600 2.373 
BUN 
Male 30 168.922 55.288 
1.520 0.136 
Female 13 142.871 41.468 
Fluid IDWG 
Male 30 1.402 0.897 
-1.611 0.115 
Female 13 1.853 0.699 
Medication 
(n= 38) 
Male 30 4.360 1.868 
-0.645 0.523 
Female 13 4.769 1.832 
Role of the nurse in 
monitoring adherence 
Male 30 36.866 2.239 
2.201 0.033* 
Female 13 35.153 2.577 
* Difference is significant at the 0.05 level. 
Table (4.13) showed that there were statistically significant differences in the mean role of 
the nurse in monitoring adherence (P= 0.033) with regard to gender in favor of females. 
The results also showed that there is no statistical significant difference in the mean of SBP 
(P= 0.806), DBP (P= 0.721), serum K
+
 (P= 0.557), serum PO4 (P= 0.874), BUN (P= 
0.136), fluids (P= 0.115) and medication (P= 0.523) with regard to gender. 
Similar results obtained in a study conducted in India and found no association between 
gender and adherence level (Beerendrakumar et al., 2018). In contrary, different results 
obtained by Naalweh et al., (2017) which showed that male patients had significantly 
higher overall adherence scores than females, while Clark-Cutaia et al., (2014) found that 
female patients reported more problems managing their diet. 
 
 
 
37 
 
Table (4.14): Differences in adherence related to age (N= 43) 
Variable Age group N Mean SD t P value 
SBP 
Less than 12 18 126.222 17.459 
-0.982 0.332 
12 and more 25 132.146 20.839 
DBP 
Less than 12 18 76.833 10.894 
-0.715 0.479 
12 and more 25 79.840 15.235 
Serum K
+
 
Less than 12 18 4.253 0.568 
-0.201 0.841 
12 and more 25 4.292 0.673 
Serum PO4 
Less than 12 18 6.863 2.297 
0.944 0.351 
12 and more 25 6.282 1.736 
BUN 
Less than 12 18 179.037 49.187 
1.974 0.055 
12 and more 25 148.093 51.755 
Fluid (IDWG) 
Less than 12 18 1.042 0.685 
-3.651 0.001* 
12 and more 25 1.896 0.802 
Medication (n= 38) 
Less than 12 15 4.466 2.166 
-0.089 0.930 
12 and more 23 4.521 1.647 
Role of the nurse in 
monitoring adherence 
Less than 12 18 36.944 2.042 
1.368 0.179 
12 and more 25 35.920 2.660 
* Difference is significant at the 0.05 level. 
 
Table (4.14) showed that there is a statistical significant difference in the mean level of 
adherence to fluid intake (P= 0.001), in which the mean of adherence among children who 
are 12 years old and more is higher than the mean of adherence among children who are 
below 12 years. Moreover, there are no statistical significant differences in SBP (P= 
0.332), DBP (P= 0.479), serum K
+
 (P= 0.841, serum PO4 (P= 0.351), BUN (P= 0.055), 
medication (P= 0.930), and role of nurses in monitoring adherence (P= 0.179) with regard 
to the age groups of children.   
Previous studies reflected variation in results. In a systematic review carried out by 
Ghimire et al., 2015), the results showed that the prevalence of nonadherence to 
medication varied between patients, and younger age was a common factor significantly 
associated with poor adherence to medication. Another study showed that younger patients 
with CKD have more problems managing their diet and restricting sodium intake (Clark-
Cutaia et al., 2014). On the other hand, Beerendrakumar et al., (2018) found that there was 
no association between age and adherence level. 
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The researcher thinks that our results are convincing because all the participants of the 
study are from childhood age and there were not big gap between different ages, besides 
that they are under control of their parents at home, and that caused similar levels of 
adherence. 
Table (4.15): Differences in adherence related to educational level of children (N= 43) 
Variable Group  n Mean SD F P value 
SBP 
Preschooler 13 124.102 21.396 
2.258 0.097 
Primary school 19 128.684 13.639 
Prep school 6 128.444 23.521 
Secondary school 5 149.333 22.361 
DBP 
Preschooler 13 73.589 11.336 
2.896 0.047 * 
Primary school 19 78.491 11.295 
Prep school 6 77.500 18.057 
Secondary school 5 93.200 14.268 
Serum K
+ 
Preschooler 13 4.230 0.577 
0.108 0.955 
Primary school 19 4.334 0.679 
Prep school 6 4.190 0.780 
Secondary school 5 4.273 0.473 
Serum PO4 
Preschooler 13 6.533 2.436 
0.422 0.738 
Primary school 19 6.771 1.736 
Prep school 6 6.477 1.890 
Secondary school 5 5.626 2.064 
BUN 
Preschooler 13 153.205 43.419 
3.595 0.022 * 
Primary school 19 183.070 56.747 
Prep school 6 153.388 38.604 
Secondary school 5 106.933 24.448 
Fluid (IDWG) 
Preschooler 13 0.928 0.699 
4.397 0.009 * 
Primary school 19 1.689 0.845 
Prep school 6 1.866 0.849 
Secondary school 5 2.160 0.469 
Medication 
(n=38) 
Preschooler 12 4.750 2.094 
2.223 0.103 
Primary school 15 4.333 1.588 
Prep school 6 5.666 1.366 
Secondary school 5 3.000 1.732 
Role of the 
nurse in 
monitoring 
adherence 
Preschooler 13 36.692 2.323 
2.357 0.087 
Primary school 19 36.789 1.960 
Prep school 6 34.000 3.847 
Secondary school 5 36.600 1.140 
Statistical testing using ANOVA,  *= Difference is significant at the 0.05 level  
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Table (4.15) showed that there was no statistical significant difference in the mean of SBP 
(P= 0.097), serum K
+
 (P= 0.955), serum PO4 (P= 0.738), medication (P= 0.103), and role 
of nurses in the monitoring of adherence (P= 0.087) with regard to child’s level of 
education. Also, there was a statistical significant difference in the mean level of DBP (P= 
0.047) with regard to the child’s level of education, Scheffe test was conducted to show the 
difference between which groups and revealed that the children who have secondary 
school; have higher DBP compared to children of lower level of education. Also, there are 
statistical significant differences in IDWG (P= 0.009) with regard to the child’s level of 
education. Scheffe test revealed that secondary school children have lower adherence to 
fluid intake. 
The results of Beerendrakumar et al., (2018) were not matching with our results as it 
showed that illiterate patients had lower adherence to diet and fluid restriction, while our 
results indicated that there were no significant differences in adherence to treatment 
program related to educational level of the pediatric patients. In my opinion, level of 
education is an important factor in adherence to treatment, and that patients with higher 
level of education will have higher awareness and understanding about their treatment 
program, which in turn will improve their adherence to treatment. The researcher explains 
our results in the context that younger patients are observed and monitored closely by their 
parents, and their parents follow the instructions of treatment, and that will improve their 
adherence to treatment, and that would lead to similar levels of adherence among younger 
children and older children.   
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Table (4.16): Difference in adherence related to place of residency (N= 43) 
Variable Group  N Mean SD F P value 
SBP 
Rafah 6 137.222 28.774 
1.726 0.164 
Khanyounis 10 137.666 16.814 
Middle 4 137.083 19.969 
Gaza 21 123.857 15.613 
North 2 113.166 27.577 
DBP 
Rafah 6 86.277 16.697 
1.542 0.210 
Khanyounis 10 80.900 16.511 
Middle 4 84.500 12.688 
Gaza 21 75.317 10.541 
North 2 66.333 7.542 
Serum K
+
 
Rafah 6 4.596 0.596 
1.622 0.189 
Khanyounis 10 4.147 0.658 
Middle 4 4.005 0.360 
Gaza 21 4.368 0.628 
North 2 3.522 0.094 
Serum PO4 
Rafah 6 6.772 2.273 
0.462 0.763 
Khanyounis 10 5.790 1.721 
Middle 4 7.091 3.493 
Gaza 21 6.668 1.765 
North  2 6.833 2.545 
BUN 
Rafah 6 148.611 49.828 
0.559 0.693 
Khanyounis 10 145.366 63.578 
Middle 4 166.666 81.270 
Gaza 21 172.174 44.664 
North 2 148.666 22.627 
Fluid (IDWG) 
Rafah 6 2.222 0.449 
3.763 0.011 * 
Khanyounis 10 1.823 0.787 
Middle 4 0.850 0.765 
Gaza 21 1.254 0.822 
North 2 2.433 0.612 
Medication 
(n= 38) 
Rafah 6 4.500 2.073 
0.693 0.602 
Khanyounis 9 3.666 1.412 
Middle 4 5.250 3.201 
Gaza 17 4.705 1.686 
North 2 5.000 1.414 
Role of the nurse 
in monitoring 
adherence 
Rafah 6 37.000 1.673 
0.425 0.790 
Khanyounis 10 35.500 3.240 
Middle 4 36.750 1.500 
Gaza 21 36.476 2.462 
North 2 36.500 2.121 
* Difference is significant at the 0.05 level (2-tailed). 
Table (4.16) showed that there were no statistical significant differences in SBP (P= 0.10), 
DBP (P= 0.19), medication (P= 0.60), diet (P= 0.44), and fluids (P= 0.09) related to place 
of residency. This result indicated that there were no statistical significant differences in 
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adherence to treatment program related to place of residency. In my opinion, GS is a 
narrow area with same climate and environment. Life conditions and culture are similar. In 
addition, the vast majority of patients receive treatment in the same unit, and follow the 
same treatment protocol and same instructions. Therefore, their adherence to treatment 
program will be almost the same regardless of their place of residency.    
Table (4.17): Difference in adherence related to Hospital (N= 43) 
Variable Group N Mean SD F P value 
SBP 
Al Najar 2 169.500 10.135 
5.952 0.002 * 
Khanyounis 5 143.200 14.530 
Al-Aqsa 1 143.333 . 
Al-Rantesy 35 125.066 17.157 
DBP 
Al Najar 2 105.500 6.363 
5.208 0.004 * 
Khanyounis 5 83.933 15.992 
Al-Aqsa 1 96.666 . 
Al-Rantesy 35 75.761 11.404 
Serum K
+
 
Al Najar 2 4.444 0.219 
1.229 0.312 
Khanyounis 5 3.802 0.439 
Al-Aqsa 1 3.988 . 
Al-Rantesy 35 4.342 .645 
Serum PO4 
Al Najar 2 4.916 1.013 
3.485 0.025 * 
Khanyounis 5 4.846 1.595 
Al-Aqsa 1 3.433 . 
Al-Rantesy 35 6.945 1.873 
BUN 
Al Najar 2 99.500 8.720 
6.707 0.001 * 
Khanyounis 5 100.533 26.270 
Al-Aqsa 1 82.666 . 
Al-Rantesy 35 175.447 46.436 
Fluid (IDWG) 
Al Najar 2 2.633 0.282 
2.292 0.093 
Khanyounis 5 2.066 0.323 
Al-Aqsa 1 1.866 . 
Al-Rantesy 35 1.391 0.872 
Medication 
(n=38) 
Al Najar 2 6.500 0.707 
1.972 0.137 
Khanyounis 5 3.600 1.816 
Al-Aqsa 1 2.000 . 
Al-Rantesy 30 4.600 1.792 
Role of the nurse 
in monitoring 
adherence 
Al Najar 2 35.000 1.414 
3.407 0.027 * 
Khanyounis 5 33.600 3.577 
Al-Aqsa 1 35.000 . 
Al-Rantesy 35 36.857 2.074 
*significant at 0.05 level 
Table (4.17) showed that pediatric patients from Al-Rantesy hospital showed statistically 
significant lowed SBP and DBP (P= 0.002 and 0.004 respectively), while serum PO4and 
BUN were significantly higher in children from Al-Rantesy hospital.  
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Al Rantesy hospital is the only hospital specialized in treatment of pediatric patients with 
CKD and the only one that have special HD unit for pediatrics. In addition, the physicians 
and nurses are well trained to treat and care for children with CKD. Furthermore, the 
machines at Al Rantesy hospitals are designed for children so the children will have better 
outcome at the end of dialysis sessions. The nurses give adequate instructions and 
education to the children and their parents about treatment and the importance of adhering 
to treatment program. All these conditions led to better adherence to treatment among 
pediatric patients with CKD at Al Rantesy hospital.  
Table (4.18): Difference in the adherence level with regard to family income 
Variable Income group N Mean SD t P value 
SBP 
Less than 1800 40 129.883 19.820 
0.263 0.794 
1800 and more 3 126.777 17.670 
DBP 
Less than 1800 40 78.433 13.559 
-0.259 0.797 
1800 and more 3 80.555 15.809 
Serum K
+ 
Less than 1800 40 4.285 0.645 
0.374 0.710 
1800 and more 3 4.144 0.193 
Serum PO4 
Less than 1800 40 6.555 2.030 
0.361 0.720 
1800 and more 3 6.122 1.468 
BUN 
Less than 1800 40 159.766 52.569 
-0.580 0.565 
1800 and more 3 178.111 57.967 
Fluid (IDWG) 
Less than 1800 40 1.543 0.851 
0.126 0.900 
1800 and more 3 1.477 1.178 
Medication (n= 38) 
Less than 1800 35 4.400 1.881 
-1.148 0.258 
1800 and more 3 5.666 0.577 
 
Table (4.18) showed that there were no statistical significant differences in SBP (P= 
0.794), DBP (P= 0.797), serum K
+
 (0.710), serum PO4 (P= 0.720), BUN (P=0.565), fluid 
(P= 0.900), and medication related to family income. 
Lower socioeconomic status is a risk factor for CKD progression to end-stage renal 
disease, and poor health outcomes. Matching results obtained by Hidalgo et al., (2013) 
who found positive association between income and kidney disease, whileClark-Cutaia et 
al., (2014) found thatincome did not influence adherence to diet, fluids, and medication. 
In my opinion, the economic situation in GS is very low with high inflation rate and 
poverty. The majority of those who are working or employed have low income. This 
situation make the whole population almost in the same level; most of the employees 
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receive between 40% – 50% of their salary with narrow gap between salaries. Therefore, 
they are almost in the same level, and in consequence, there were no differences in their 
adherence to treatment related to income.   
Table (4.19): Difference in adherence related to fathers' level of education (N= 43) 
Variable  Group  N Mean SD F  P value 
SBP 
Prep and less 17 132.588 13.882 
0.349 0.708 Secondary  11 126.424 16.460 
University  15 128.733 26.599 
BP 
Prep and less 17 80.156 12.783 
0.502 0.609 Secondary  11 75.060 13.329 
University  15 79.377 14.889 
Serum K
+ 
Prep and less 17 4.245 .655 
0.914 0.409 Secondary  11 4.106 .519 
University  15 4.435 .659 
Serum PO4 
Prep and less 17 6.086 1.606 
0.903 0.414 Secondary  11 6.512 2.067 
University  15 7.033 2.305 
BUN 
Prep and less 17 155.745 53.031 
0.142 0.868 Secondary  11 165.636 61.772 
University  15 163.688 47.410 
Fluid (IDWG) 
Prep and less 17 1.666 1.018 
0.515 0.580 Secondary  11 1.315 .748 
University  15 1.557 .757 
Medication (n= 
38) 
Prep and less 15 3.733 1.791 
3.056 0.060 Secondary  18 5.222 1.699 
University  5 4.200 1.788 
 
Table (4.19) showed that there were no statistical significant differences in SBP (P= 
0.708), DBP (P= 0.609), serum K
+
 (P= 0.409), serum PO4 (P= 0.414), BUN (P= 0.868), 
fluid (P= 0.580), medication (P= 0.060), related to fathers' level of education. This result 
indicated that there were no statistical significant differences in adherence to treatment 
related to fathers’ level of education. It is worth to say that fathers’ level of education is an 
important factor in adherence of their children to treatment, and that fathers with higher 
education, their children will have better adherence to treatment. In my opinion, regardless 
of their level of education, the fathers care about their children and want them to be healthy 
and in good condition. Therefore, they monitor their children, and give them medication as 
prescribed and accompany them to the hospital for HD. Therefore, there were no 
significant differences in adherence to treatment.  
44 
 
Table (4.20): Difference in adherence related to mothers' level of education (N= 43) 
Variable Group  N Mean SD F P value 
SBP 
Prep and less 15 131.622 17.052 
0.125 0.883 Secondary 19 128.193 20.448 
University 9 129.518 23.119 
DBP 
Prep and less 15 79.466 13.818 
0.232 0.794 Secondary 19 77.017 14.038 
University 9 80.407 13.108 
Serum K
+ 
Prep and less 15 4.255 0.667 
1.080 0.349 Secondary 19 4.168 0.636 
University 9 4.537 .50298 
Serum PO4 
Prep and less 15 5.753 1.616 
1.832 0.173 Secondary 19 6.887 2.303 
University 9 7.048 1.564 
BUN 
Prep and less 15 151.577 54.607 
0.456 0.637 Secondary 19 163.193 56.673 
University 9 172.296 40.782 
Fluid (IDWG) 
Prep and less 15 1.624 0.975 
0.132 0.876 Secondary 19 1.468 0.841 
University 9 1.544 0.775 
 
Table (4.20) showed that there were no statistical significant differences in SBP (P= 
0.883), DBP (P= 0.974), serum K
+
 (P= 0.349), serum PO4 (P= 0.173), BUN (P= 0.637), 
fluid (P= 0.876), medication (P= 0.060) related to mothers' level of education. 
This result indicated that there were no statistical significant differences in adherence to 
treatment related to mothers’ level of education. It is worth to say that mothers’ level of 
education is an important factor in adherence of their children to treatment, and that 
mothers with higher education, will have better understanding of the disease process and 
special precautions needed to avoid complications and worsening the condition of their 
children.  Therefore, their children will have better adherence to treatment. In my opinion, 
regardless of their level of education, the mothers care about their children and want them 
to be healthy and in good condition. So, they monitor their children, and give them 
medication as prescribed and accompany them to the hospital for HD. Therefore, there 
were no significant differences in adherence to treatment.  
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Table (4.21): Difference in adherence related to number of years on dialysis (N= 43) 
Variable Group  N Mean SD t P value 
SBP 
< 5 years 26 126.34 19.95 
-1.396 0.170 
≥ 5 years  17 134.74 18.19 
DBP 
< 5 years 26 76.43 13.63 
-1.297 0.202 
≥ 5 years  17 81.86 13.06 
Serum K
+
 
< 5 years 26 4.28 0.59 
0.144 0.886 
≥ 5 years  17 4.25 0.69 
Serum PO4 
< 5 years 26 6.83 2.04 
1.260 0.215 
≥ 5 years  17 6.05 1.85 
BUN 
< 5 years 26 176.32 52.38 
2.507 0.016 * 
≥ 5 years  17 137.68 44.37 
Fluid (IDWG) 
< 5 years 26 1.31 0.96 
-2.257 0.029 * 
≥ 5 years  17 1.88 0.52 
Medication (n= 38) 
< 5 years 22 4.72 1.85 
0.889 0.380 
≥ 5 years  16 4.18 1.83 
*significant at 0.05 level 
Table (4.21) showed that CKD patients who are on HD for less than five years had 
statistically significant higher level of BUN (P= 0.016), while those who are on HD for 
five years and more had statistically significant higher IDWG (P= 0.029). The results also 
showed that there were no statistical significant differences in SBP (P= 0.170), DBP (P= 
0.202), serum K
+
 (P= 0.886), serum PO4 (P= 0.215), and medication (P= 0.380). Matched 
results obtained by Obialo et al., (2012) which showed that years on dialysis did not affect 
adherence to treatment program, and only 2.4% of patients had missed treatments.  
In my opinion, length of years on HD may affects adherence to treatment. By increase of 
the years on dialysis, the patient and his family get fed up from going to the hospital three 
days per week, so sometimes they miss some HD sessions especially if they feel better. On 
the other hand, fear of developing complication may enforce the patient to follow the 
prescribed treatment and that would improve their adherence to treatment program,  
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5 Chapter Five 
Conclusion, recommendations, and suggestions for further research 
5.1 Conclusion 
Adherence is a major problem in pediatric patients with CKD. Patients can be nonadherent 
with different aspects of their treatment, which includes medications, treatment regimens, 
and dietary and fluid restrictions.  
This study concluded that two-thirds of the study participants were male pediatric patients 
and one-third of them were male pediatric patients, with mean age 11.78±4.52 years, and 
mean number of years on dialysis was 3.73 years. In addition, 7% of pediatric patients 
were fully adhered to diet, 88.4% were fully adhered to fluids intake, 36.8% were fully 
adhered to anti-hypertensive medication, 93% reported that the nurses were fully 
performing their role in monitoring the adherence of patients to diet, fluids intake, and 
medication. There was statistically significant correlation between SBP, DBP and number 
of hours per HD session.  
There were no statistical significant differences in BP, diet, fluid intake, and medication 
related to gender, age of the child, educational level of the child (except for DBP), place of 
residency, and family income, parents’ level of education, and number of years being on 
HD. While significant differences existed in relation to the hospital (in favor of Al Rantesy 
hospital). 
5.2 Recommendations 
In the light of the study results, the researcher recommends the following: 
- The Health promotion department at MOH should develop and implement an 
educational program about appropriate diet, fluid intake, and medication to improve 
adherence and avoid complications that may result from nonadherence to treatment. 
- The need to use media and TV programs to increase public awareness and 
understanding of the disease process and preventive measures that eliminate relevant 
contributing factors to non-adherence in CKD patients. 
- Activate school health counseling with MOH to increase their visits and educational 
programs in the schools to increase the awareness of children about preventive 
measures of renal disease. 
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- Ensure having written, clear protocols and guidelines that specify the process of 
hemodialysis procedures and adherence issues to make sure that every patient receives 
the treatment in the same way. 
- Utilizing Nutritionists especially the nurses who have master degree in clinical 
nutrition to participate in health education programs regarding diet for children with 
renal failure.   
5.3 Suggestions for further research 
- Further studies should be conducted to examine the risk factors that contribute to the 
development of CKD in children in Gaza Strip. 
- Further studies should be conductedaiming to identify barriers that hinder the 
adherence of children to treatment program. 
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تحيةطيبةوبعد،،، ... عزيزتي /عزيزي
 –عفاف عبد المطيف أبو نمر، الممتحقة ببرنامج ماجستير تمريض أطفال، جامعة القدس / أنا الباحثة
العلاقة بين ضغط الدم ومدى الالتزام بالحمية الغذائية، وكمية : أبو ديس، أقوم بإعداد بحث بعنوان
 .السوائل، والأدوية لدى أطفال غسيل الكمى في قطاع غزة
نأمممنسيادتكمالتكرموالمشاركةفيتعبئةهذاالاستبيانوالذييهدفمعرفة العلاقة بين ضغط الدم ومدى الالتزام 
بالحمية الغذائية، كمية السوائل، والأدوية الموصوفة لدى الأطفال الذين يخضعون لجمسات غسيل 
 .الكمى في قطاع غزة
دقيقة وستكون لمرة واحدة، مع العمم 51-02  سيتم إجراءهذهالدراسةمنخلالالاستبانة،وهيتستغرقحوالي 
أن الموافقة طوعية ولكمالحقفيعدم المشاركة في الدراسة، مع التأكيد عمى سريةالمعموماتالتيسيتم جمعها، 
. حيث أنها سوف تستخدم لأغراض البحث العممي فقط
شاكرينمكمحسنتعاونكم ،،، 
الباحثة 
 عفاف أبو نمر
 : .................الأم/ توقيعالأب 
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Annex (2): Adherence to diet, fluids, and medication questionnaire 
Part (1): Demographic characteristics 
 
Gender  □ Male    □ Female        
Age ……… years ........month  
Educational Level □Primary □Elementary □Secondary 
Residence □Rafah □Khanyounis □Middle area 
□Gaza □North Gaza  
Hospital □Alnajjar □Nasser □Alaqsa 
□Shifa □Rantisi □……… 
Average family income …………. NIS   
Father education 
□Illiterate □Primary school □Preparatory school  
□Secondary □University □High education  
Mother education 
□Illiterate □Primary school □Preparatory school  
□Secondary □University □High education  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Part (2): Medical history of the patient 
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Hypertension  □Yes 
□No  
Heart disease  □Yes 
□No  
Diabetes Mellitus type I  □Yes 
□No  
Other diseases ………….………………………………….. 
Years number of dialysis …………./ Years 
Session/ week …………./ week 
Hours /session …………. Hours 
Emergency dialysis  …………. 
Times/month 
  
Type of dialysis machine □Gambro  □Braun □Fresenius 
 
 
Part (3): Adherence to diet 
 
Indicator Reading 1 
Before session 1 
Reading 2 
Before session 2 
Reading 3 
Before session 3 
Pre dialysis serum K _____ mg/dl _____ mg/dl _____ mg/dl 
Pre dialysis serum Phosphorus 
_____ mg/dl _____ mg/dl _____ mg/dl 
Pre dialysis serum BUN 
_____ mg/dl _____ mg/dl _____ mg/dl 
 
 
 
 
 
 
Part (4): Adherence to fluids 
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Indicator 
Weight upon arrival 
for this session (pre 
dialyses) 
Weight at the end of 
previous session(post 
dialyses) 
TargetWeight 
IDWG session 1 
_____ Kg _____ Kg _____Kg  
IDWG session 2 
_____ Kg _____ Kg _____Kg  
IDWG session 3 
_____ Kg _____ Kg _____Kg 
 
Part (5): Measurement of Blood Pressure 
Indicator 
Reading 1 
Before session 1 
Reading 2 
Before session 2 
Reading 3 
Before session 3 
Pre-dialysis Blood Pressure  ____/____ mmHg ____/____ mmHg ____/____ mmHg 
Post-dialysis Blood Pressure  ____/____ mmHg ____/____ mmHg ____/____ mmHg 
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Part(6):Measurement role of the nurses working in hemodialysis units in monitoring 
the adherence of pediatric patients to fluid, diet and medication. 
No. Item  Yes  No  
1- 
Are your blood pressure taken by the nurse during dialysis session three 
times? 
  
2- Your weight is measured before dialysis session by the nurse?   
3- Your weight is measured after dialysis session by the nurse?   
4- Have you given instructions regarding food during dialysis?   
5- 
Are the nurse advice patient / parents about the correct time of medications 
before dialysis session? 
  
6- 
Are the nurse advice patient / parents about the correct time of medications 
after dialysis session? 
  
7- Do the nurse make check for the patient weight at the end of dialysis?   
8- 
Are you instructed by nurse to avoid excessive drinking water during 
dialysis? 
  
9- 
Did the nurse tell you about the amount of fluid which is allowed during the 
day? 
  
10- 
Did the nurse tell you about the type of food which is allowed during the 
day? 
  
11- 
Did the nurse tell you about the amount of food which is allowed during the 
day? 
  
12- 
Did the nurse inform the patient and /or the parents that the weight between 
the sessions; should not be more than the 5% of overall weight? 
  
13- 
Did the nurse tell the patients and /or the parents that the increase in the dry 
weight should be based on the child growth and his/her age? 
  
14- 
Are you advised by the nurse about the importance of adherence to diet to 
prevent complications? 
  
15- 
Are you advised by the nurse about the importance of adherence to fluids to 
prevent complications? 
  
16- 
Are you advised by the nurse about the importance of adherence to 
medications to prevent complications? 
  
17- 
Did the nurse tell you about the correct time of intake your drug must be deal 
with after dialysis session? 
  
18- 
Did the nurse teach you about the complications of the disease, 
complications, diet, fluids intake and medications for the patient and parents? 
  
19- Did the nurse teach you about the time of taking medications?   
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مقياس مورسكي للالتزام بالعلاج :  امسا ً
الرجاء الإجابة عمى هذه الأسئمة بناء عمى تجربتك الش صية في تناول الأدوية 
 لا نعم الفقــــــــــــــــــــرة
   هم حىسى في بعض الأحيان أن حخىاول دوائك انخاص بارحفاع ضغط انذو مه غير قصذ؟.1
خلال الأسبىعيه انماضييه، هم كان هىانك أياو وسيج فيها حىاول دوائك انخاص بارحفاع . 2
 ضغط انذو؟
  
هم قمج بانخىقف عه حىاول علاجك بذون أن حخبر انطبيب، لأوك حشعر باسخياء عىذ حىاول . 3
 دوائك انخاص بارحفاع ضغط انذو؟
  
عىذما حغادر انبيج أو حسافر، هم حىسى في بعض الأحيان أن ححضر دوائك انخاص بارحفاع . 4
 ضغط انذو مه غير قصذ؟
  
   هم حىاونج دوائك انخاص بارحفاع ضغط انذو في الأمس؟ .5
عىذما حشعر بان ضغط دمك ححج انسيطرة، هم حخىقف في بعض الأحيان عه حىاول دوائك . 6
 انخاص بارحفاع ضغط انذو؟
  
حىاول انذواء بشكم يىمي هى إزعاج حقيقي بانىسبت نهبعض، هم شعرث يىما بأوك مىسعج .7
  بشان الانخساو بخىاول انعلاج انخاص بارحفاع ضغط انذو؟
  
 :كم مزه في الغالب تجد صعوبت أن تتذكز تناول أدويت ارتفاع ضغط الدم؟ الزجاء وضع دائزة حول ما يناسبك. 8
 كم الأوقاث□ في بعضالأحيان                 □وادرااً                         □ مطهقا□
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Annex (3): Names of experts 
 
Dr. Mustafa Al Eila Director of Al Rantesy Specialized Pediatric Hospital 
Dr. Osama Elian Palestine University 
Dr. Alam Abu Hamda Director of SCBU at Al Shifa Medical Complex 
Dr. Ryad Barbakh Director of Dialysis Unit at Nasser Medical Complex 
Dr. Ahmed Al Shaer Islamic University - Gaza 
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Annex (4): Approval from Helsinki Committee 
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Annex (5): Approval from Ministry of Health 
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Annex (6): Map of Palestine 
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العلاقة بين ضغط الدم ومدى الالتزام بالحمية الغذائية، وكمية السوائل، والأدوية : عنوان الدراسة
. لدى أطفال غسيل الكمى في قطاع غزة
عفاف أبو نمر : إعداد
سامر النواجحة . د: إشراف
مم ص الدراسة 
هدفت هذه الدراسة إلى معرفة العلاقة بين ضغط الدم ومدى الالتزام بالحمية الغذائية، وكمية السوائل 
استخدمت . والأدوية لدى أطفال غسيل الكمى الذين يعانون من الفشل الكموي المزمن في قطاع غزة
 34 طفًلا، وتكونت عينة الدراسة من 05تكون مجتمع الدراسة من . الباحثة المنهج الوصفي التحميمي
%.  7.78طفًلا يخضعون لعممية غسيل كموي حيث بمغت نسبة الاستجابة لممشاركة في الدراسة 
لجمع البيانات قامت الباحثة بإعداد استبانة تكونت من المعمومات الشخصية، الالتزام بكل من الحمية 
الغذائية، كمية السوائل، الأدوية الموصوفة، دور التمريض في متابعة مدى الالتزام بالبرنامج العلاجي، 
وقد تم توزيع الاستبانة عمى مجموعة من . ومقياس موريسكي لمعرفة مدى الالتزام بالأدوية الموصوفة
 طفًلا 02المحكمين بهدف التأكد من صدق المحتوى، كما تم إجراء دراسة استطلاعية عمى عينة من 
 لاستبانة دور التمريض في متابعة مدى التزام المرضى بالبرنامج 97.0وبمغت قيمة ألفا كرونباخ 
ولتحميل البيانات فقد تم استخدام .  عمى مقياس موريسكي29.0العلاجي، كما بمغت قيمة ألفا كرونباخ 
 وتضمنت المعالجات الإحصائية التكرارات، 22 SSPSبرنامج الرزم الإحصائية لمعموم الاجتماعية 
، تحميل التباين الأحادي، واختبار )ت(النسب المئوية، المتوسط الحسابي، الانحراف المعياري، اختبار 
.   بيرسون لمعلاقة بين المتغيرات
من الأطفال % 2.03من عينة الدراسة كانوا من الأطفال الذكور و% 8.96أظهرت نتائج الدراسة أن 
منهم ممتحقين % 2.44، كما أن 25.4 سنة بانحراف معياري 87.11الإناث، وبمغ متوسط أعمارهم 
. لم يمتحقوا بالمدارس بعد% 2.03بالمدرسة الابتدائية و
من الأطفال لديهم ضغط دم مرتفع ويخضع أطفال عينة الدراسة لعممية % 4.88وبينت النتائج أن 
وبينت النتائج أن درجة الالتزام بالحمية . ) سنة37.3= م( سنوات 8 شهور إلى 6غسيل الكمى منذ 
الغذائية كانت ضعيفة ويظهر ذلك من نتائج تحميل الدم التي بينت أن مستوى البوتاسيوم قبل عممية 
، مستوى الفسفور )ديسيمتر/ مغم94.5= م(ديسيمتر /  مميغرام72.7 إلى 72.4الغسيل تراوح بين 
، ومستوى اليوريا تراوح بين )ديسيمتر/  مغم25.6= م(ديسيمتر /  مغم38.11 إلى 76.2تراوح بين 
ديسيمتر، وأظهرت النتائج أن الوزن المكتسب بين الغسيل السابق والغسيل /  مغم0.292 إلى 33.55
 86
 
، كما أن الالتزام بأدوية ضغط ) كغم37.1= م( كيمو غرام 38.3 غرام إلى 01.0الحالي تراوح بين 
%). 41.15(الدم كان منخفضًا بحسب الدرجات عمى مقياس موريسكي
بدورهم في متابعة درجة التزام الأطفال  )%3.19(وبينت النتائج أن الممرضين التزموا بدرجة عالية 
التزموا % 4.88من الأطفال التزموا بالحمية الغذائية بشكل كامل، % 7بالبرنامج العلاجي، كما أن 
التزموا بتناول أدوية ضغط الدم بشكل كامل، وبمغ % 8.63بكمية السوائل المسموحة بشكل كامل، 
 مغم زئبق ومتوسط ضغط الدم الانبساطي 66.921متوسط ضغط الدم الانقباضي قبل جمسة الغسيل 
.  مغم زئبق85.87
وأظهرت النتائج وجود علاقة دالة إحصائيًا بين كل من ضغط الدم الانبساطي وكمية السوائل التي 
، وضغط الدم وعدد الساعات )40.0 =P(، الغذاء والأدوية المتناولة )30.0 =P(يتناولها الأطفال 
.  لكل جمسة غسيل
كما بينت النتائج عدم وجود فروق ذات دلالة إحصائية في درجة الالتزام بالبرنامج العلاجي تعزى لكل 
، مكان السكن، )ما عدا ضغط الدم الانبساطي(من الجنس، عمر الطفل، المستوى التعميمي لمطفل 
الدخل الشهري، المستوى التعميمي لموالدين، عدد سنوات الغسيل الكموي، في حين أن درجة الالتزام 
كانت مرتفعة وذات دلالة إحصائية لدى الأطفال الذين يخضعون لعممية غسيل الكمى في مستشفى 
. الشهيد عبد العزيز الرنتيسي التخصصي للأطفال مقارنة بالمستشفيات الأخرى
في الإجمال فقد أظهرت الدراسة الحاجة إلى التركيز عمى العوامل التي تحد من التزام الأطفال 
بالبرنامج العلاجي، والحاجة إلى تحديد المشكلات في النظام الصحي التي تحد من القدرة عمى الالتزام 
بالبرنامج العلاجي، بالإضافة إلى الدور الهام الممقى عمى عاتق التمريض في تحديد المعيقات التي 
تحد من درجة التزام الأطفال بالبرنامج العلاجي، ووضع استراتيجيات تهدف إلى المساعدة في رفع 
.   درجة الالتزام بالبرنامج العلاجي
 
 
